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Abstract 
Background Schizophrenia is a neurodevelopmental disorder with many genetic variants of 
individually small effect contributing to phenotypic variation. Lower cortical thickness (CT), 
surface area (SA) and cortical volume (CV) have been demonstrated in schizophrenia. 
Furthermore, a range of obstetric complications (e.g. lower birth weight) are consistently 
associated with an increased risk for schizophrenia. We investigated whether a high 
polygenic risk score for schizophrenia (PGRS-SCZ) is associated with CT, SA and CV in UK 
Biobank, a population-based sample, and tested for interactions with birth weight. 
Methods Data were available for 2,864 participants (nmales/nfemales = 1382/1482; mean age 
=2.35 years, ±S.D = 7.40). Linear mixed models were used to test for associations between 
PGRS-SCZ and CV, SA and CT and between PGRS-SCZ and birth weight. Interaction 
effects of these variables on cortical structure were also tested.  
Results We found a significant negative association between PGRS-SCZ and global CT; a 
higher PGRS-SCZ was associated with lower CT across the whole brain. We also report a 
significant negative association between PGRS-SCZ and insular lobe CT. PGRS-SCZ was 
not associated with birth weight and no PGRS-SCZ×birth weight interactions were found. 
Conclusions These results suggest that individual differences in CT are partly influenced by 
genetic variants and are most likely not due to factors downstream of disease onset. This 
approach may help to elucidate the genetic pathophysiology of schizophrenia. Further 
investigation in case-control and high-risk samples could help identify any localised effects 
of PGRS-SCZ, and other potential schizophrenia risk factors, effects on CT as symptoms 
develop. 
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Text 
1. Introduction  
Schizophrenia is a heterogeneous psychiatric disorder with twin heritability estimates (h2) of 
~80% (1-3). Recent evidence suggests that the disorder is polygenic in nature, (1-4) with 
genome-wide association studies (GWAS) identifying schizophrenia-inferring loci (3, 5, 6). 
Supporting a neurodevelopmental theory of schizophrenia, cortical decreases have been 
consistently associated with the disorder, thought to predate disorder onset (7-9) and are 
caused by a combination of genetic and environmental factors (7, 8). Limited research has 
explored the links between polygenic risk for schizophrenia (PGRS-SCZ) and cortical 
structure with consideration of other schizophrenia risk factors. 
 
Differences in some aspects of brain structure have been consistently detected in groups of 
schizophrenia patients compared to healthy controls (10). Recently, the field has moved 
towards studying cortical volume (CV), thickness (CT) and surface area (SA) of the brain. 
These metrics are considered to have distinct developmental trajectories (11) and are 
heritable; h2 ranges from 66-97% for CV (12) and averages around 80% for global CV (13, 
14), 81% for CT (15), and 89% for SA (15).  
 
CV has been most studied in schizophrenia, reporting lower CV in widespread areas of the 
brain in patients (10, 16-24) and in the healthy relatives of individuals with schizophrenia as 
compared to controls (21, 25-27). However, as CV is the product of CT and SA (11, 15, 28), 
studying volume alone may obscure some schizophrenia and brain structure associations (10, 
15). Lower CT has been evidenced in several brain regions (10, 29-35) and widespread areas 
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across the cortex (10, 21, 31, 35-40) in those at greater genetic risk of/with schizophrenia. 
Furthermore, CT differences have been found in frontal and temporal lobes of individuals at 
familial high-risk of schizophrenia when compared to controls (21, 40-44) and thus may be 
more easily identified in those with a higher genetic risk of the disorder. SA has been less 
researched, and with more contradictory results (24). Some studies suggest SA is lower in 
schizophrenia patients compared to controls both globally (45) and in specific regions (18, 
24, 30, 35, 45), whereas others have found SA to be higher (34, 46) or no different (36, 47) in 
these groups.  
 
Recently, large GWAS (nindividuals =36,989 cases, 113,075 controls) have been used to derive 
PGRS-SCZ (3, 5, 6); higher scores relating to a greater risk of developing schizophrenia. 
PGRS-SCZ allows for the assessment of genetic liability in the general population – even 
among people who may never develop schizophrenia - and enables use of large-scale samples 
such as UK Biobank (UKB; http://www.ukbiobank.ac.uk/).  
 
A small number of studies have tested PGRS-SCZ in relation to structural brain imaging 
phenotypes with inconsistent results. Reus et al. (48) found no associations between regional 
subcortical volume or white matter microstructure and PGRS-SCZ, using a subset of the 
same sample as the current study (n = 978), but did not assess any cortical metrics. Some 
studies have reported higher PGRS-SCZ to be associated with a decrease in global gray 
and/or white matter volume (49-51) (nindividuals range = 89-274) with relatively small effect 
sizes and amount of variance explained (β = - .151, ∆R2 = .023 (change in R2 for regional 
white matter volume when PGRS-SCZ is added to hierarchical regression analyses), R2 = 
.042 (total brain volume); whilst others did not find an effect (52, 53) (nindividuals range = 122-
763). Higher PGRS-SCZ has also been previously associated with lower global CT in a case-
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control sample, regardless of group (54) (η2 = .116 (left hemisphere); .121 (right 
hemisphere)). Lancaster et al (55) found no such association in a control sample but did 
report nominal regional CT effects. Due to the limited sample sizes in these CT investigations 
(nindividuals range = 75-99), further testing is required.   
 
Another important consideration, as per neurodevelopmental theories of the disorder (7-9), 
relates to potential effects of other risk factors for schizophrenia and their interactions 
between schizophrenia liability and cortical structure. Several obstetric complications (OCs), 
for example, have been consistently identified as risk factors for schizophrenia (56-63) with 
some, such as birth weight, considered to be influenced by both genetic and environmental 
components (64). Previous studies have also suggested that OCs are associated with greater 
cortical structure deficits in schizophrenia patients compared to controls (27, 63).  All three of 
the current cortical metrics are considered to be highly susceptible to both genetic and 
environmental factors (65) with subtle differences in birth weight, in particular, previously 
linked to lower CV, SA (66-68) and CT (67) later in life. Moreover, evidence suggests that a 
genetic liability for schizophrenia can lead to higher susceptibility for experiencing OCs (69, 
70) and that these complications could themselves be associated with the schizophrenia-
associated genes (56). Given these findings, we also tested whether PGRS-SCZ was 
associated with birth weight and if any interactions were present between the two in relation 
to cortical structure.  
 
The current study tests for associations between PGRS-SCZ and cortical structure (CV, SA 
and CT), in a population-based sample, with the specific hypothesis that a higher PGRS-SCZ 
would be associated with lower global CT. Lower global, frontal and temporal CT in 
particular has been found in those at familial high-risk and global CT has been previously 
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associated with a higher PGRS-SCZ (54). Furthermore, we predicted that these effects would 
interact with birth weight; individuals with a higher PGRS-SCZ with lower birth weight 
would have smaller CV, CT and SA. 
 
2. Methods and Materials 
2.1 Participants Detailed participant information for UKB has been reported previously (71) 
(http://www.ukbiobank.ac.uk/participants/) and in Supplementary Material. The current 
sample included individuals with complete genetic and cortical data for three parameters (CV, 
SA and CT). Participants were excluded based upon overlap in Psychiatric Genomics 
Consortium (PGC) prediction samples and schizophrenia status, see Derivation of Polygenic 
Risk Scores and Supplementary Material. Global cortical outliers (±3 S.Ds), were removed 
for all three parameters. Thus, the current sample consisted of 2,864 individuals (nmales/nfemales 
=1382/1482; mean age at time of scan =62.35 years, ±S.D =7.40 years, range =46-78 years). 
Ethical approval for UKB was received from the research ethics committee (REC reference 
11/NW/0382) under application 4844. Informed consent was provided by all participants 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=200). 
 
2.2 Imaging Procedures UKB imaging details are described in full elsewhere (71-73) 
(https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). Briefly, structural images were 
acquired on a single 3T Siemens Skyra scanner. Structural brain images were acquired in the 
sagittal plane using a T1-weighted MPRAGE sequence (1×1×1mm resolution). Further 
information on the imaging protocol (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367) 
and acquisition parameters (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977) are 
documented online. Brain scans were processed locally in Edinburgh, using FreeSurfer (v5.3, 
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http://surfer.nmr.mgh.harvard.edu/), on a server cluster at Centre for Cognitive Ageing and 
Cognitive Epidemiology (CCACE, http://www.ccace.ed.ac.uk/). 
 
2.3 MRI Analysis T1-weighted volumes from the first UKB imaging release were used to 
derive cortical measures of CT (mm), SA (mm2) and CV (mm3). Parcellation was conducted 
using the Desikan-Killiany neuroanatomical atlas (74), generating 34 bilateral cortical 
parcels, attributed to eight lobar structures, each with CV, SA and mean CT measures (74). 
Eleven parcels were combined into four larger regions as previous  (75, 76); resulting in 27 
bilateral regions of interest in total, see Supplementary Material. X, Y and Z co-ordinates 
of the centre of the brain mask within the scanner were fitted as covariates for the current 
analyses to account for varying head positions in the scanner; see Supplementary Material.  
 
2.4 MRI Quality Control Procedures Quality checks of T1-weighted images were initially 
carried out by UKB (Brain Imaging Documentation V1.1, http://www.ukbiobank.ac.uk,(77)) 
with further local Quality Control (QC) procedures (see (76), 
http://enigma.ini.usc.edu/protocols/imaging-protocols/ and Supplementary Materials. 
 
2.5 Genotyping and Imputation Processing Procedures for genotyping, imputation and 
quality control for UKB have been reported previously (79-81). Briefly, 488,377 blood 
samples were assayed using two different genotyping arrays; Applied Biosystems UK 
BiLEVE Axiom Array by Affymetrix (79) and Applied Biosystems UKB Axiom Array 
(http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UK-Biobank-Axiom-Array-
Content-Summary-2014.pdf), see Supplementary Material.  
Genetic QC was performed using the approach described by Howard et al. (81). Firstly, 
participants were excluded based on shared genetic relatedness up to the third degree using 
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kinship coefficients (>.044) identified using the KING toolset (82), as previous (81, 83). To 
maximise the sample, we subsequently added back in one member from each group of related 
individuals, using a genomic relationship matrix, and selected only those with a relatedness 
of less than .025 with any other individual. Individuals were also excluded based upon a 
combination of both self-reported ethnicity and a principal component (PC) analysis (see 
Supplementary Material) which revealed individuals with similar ancestral backgrounds. 
Final QC exclusion criteria included variant missing-ness per individual (>2%), gender 
mismatch, variant call rate (<98%), Hardy-Weinberg equilibrium (P < 10-6), minor allele 
frequency < .01, an imputation quality < .1, resulting in 331,374 individuals and 7,730,951 
variants. 
 
2.6 Derivation of Polygenic Risk Score PGRS-SCZ were constructed using PLINK v1.9 (84) 
to calculate the sum of all alleles that are associated with schizophrenia, across many genetic 
loci, and weighting these alleles by their effect sizes. These effect sizes have been previously 
estimated (PGC-SCZ, https://www.med.unc.edu/pgc/pgc-workgroups) GWAS (36, 989 cases, 
113,075 controls) (5). Individual identifiers were not available for PGC-SCZ within this 
sample thus, in an attempt to reduce the likelihood of any potential overlap between PGC-
SCZ and the current sample, individuals form the PGC Major Depressive Disorder (MDD) 
working group prediction sample (85) were excluded (n = 92). For the same reason, UKB 
individuals who reported a diagnosis of schizophrenia were also excluded (n =812, see 
Supplementary Fig S1). Schizophrenia status was determined from two separate variables 
within UKB: International Classification of Diseases (ICD-10) diagnosis 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=41202; F20-F29 Schizophrenia, schizotypal 
and delusional disorders) and non-cancer illness 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20002). The former is a summary of the 
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distinct diagnoses given from episodes in hospital; the latter was coded by a trained nurse 
based on the description of a non-cancer illness given by the participant.  
 
To create a SNP-set in approximate linkage equilibrium, clump-based linkage disequilibrium 
pruning was performed with a r2 of < 0.25 within a 200kb window. For the remaining SNPs, 
marker weights (logarithm of the Odds Ratio) and p-value association statistics for individual 
SNPs were derived from the most recent PGC GWAS of schizophrenia (9.8 million 
autosomal SNPs) (5). Five scores were generated for each individual, using SNPs selected 
according to the significance of their association with the phenotype in the discovery GWAS 
at nominal P-value thresholds of ≤  0.01, 0.05, 0.1, 0.5, 1, as previously described (3). The 
SNP inclusion threshold was set at P ≤ 0.1 for the current paper, as this threshold was shown 
to explain the most phenotypic variance in the discovery cohort (5). There were 86,124 SNPs, 
available in the current sample after QC, using the P ≤ 0.1 threshold (see Supplementary 
Material). For results produced using the remaining SNP inclusion thresholds (P ≤ 0.01, 
0.05, 0.5 and 1), see Supplementary Materials. PCs were also calculated to account for 
population stratification (see Supplementary Materials), the first 15 PCs were used in the 
current analysis. 
 
2.7 Measure of Birth Weight Participants were asked to provide their own BW information 
(see Supplementary Materials). Recalled BW has been shown to have high agreement with 
recorded BW and considered a valid measure for epidemiological studies (86). BW range = 
.91-5.78kg (mean = 3.40kg, ±S.D = .61kg). 
 
2.8 Covariates Socioeconomic Deprivation 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=189) was measured using the Townsend 
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deprivation index (see Supplementary Materials) (range = -6.26 – 9.16, mean = -1.98, ±S.D 
=2.68). Standing height (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=50) was measured 
using a Seca 202 device (range = 143 – 196cm, mean = 169.74cm, ±S.D = 9.20cm). 
 
2.9 Statistical Analysis  
All analyses were conducted in R (v3.2.3). 
2.9.1 Associations Between PGRS-SCZ and Cortical Structure Linear mixed effects (LME) 
models (package “nlme”, v3.1-127) were used to determine whether PGRS-SCZ were 
associated with cortical structures. 
LME models were first conducted in a repeated measures format, with hemisphere fitted as a 
random factor, as previous (48, 78). PGRS-SCZ*hemisphere interactions were also tested to 
determine if analysis of left and right homologous structures separately was required.  
For the main analyses, an LME model was tested which included age, age2, sex, genotype 
array, 15 PCs and X, Y and Z co-ordinates of the brain mask within the scanner, as fixed 
effects. Intracranial volume (ICV) was included as a fixed effect for lobar and parcellation 
analyses.  
Standardised regression coefficients are reported throughout. Utilising the ‘p.adjust’ function 
(‘stats’ package v3.2.3), the false discovery rate (FDR) method, with a rate of P < .05 (87), 
was used to correct results for multiple comparisons. Henceforth, FDR-corrected P values 
will be referred to as p(FDR).  
In the first instance and in line with our main hypothesis, we tested for associations between 
PGRS-SCZ and global cortical structure. These PGRS-SCZ global cortical associations were 
FDR corrected across CV, CT and SA at each PGRS-SCZ SNP inclusion threshold 
individually. Associations between PGRS-SCZ and regional cortical structures were tested 
for if global cortical associations were evident; first at the lobar and then parcellation level. 
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Thus, for post-hoc regional associations, p(FDR) was calculated for each cortical metric 
individually, by correcting over all 8 possible lobar structures or 27 parcellations for each 
PGRS-SCZ P-threshold. 
In the main text, we only report statistically significant associations (p(FDR) < .05) between 
PGRS-SCZ and cortical brain structure. Furthermore, the reported results were analysed 
using the SNP inclusion threshold of P ≤ 0.1 as this threshold explained the most phenotypic 
variation in the discovery cohort (R2 = ~0.18 (5)). Non-significant associations and results for 
all other thresholds as can be found in Supplementary Material.  
 
2.9.2 Associations Between PGRS-SCZ and Birth Weight Using the full sample of 
individuals with cortical, genotype and BW information, excluding global cortical outliers (n 
=1,659, nmales/nfemales =696/963; mean age at time of scan =60.79 years, ± S.D =7.41 years, 
range = 46-78 years), a generalised linear model regression (package “glm2”, v1.1.3) was 
used, to test for associations between PGRS-SCZ and birth weight. This model included all 
fixed effects used in the previous model, with the addition of height and socioeconomic 
deprivation, see (67, 68), as fixed effects. LME models, using these same fixed effects, 
hemisphere as a random factor and an additional PGRS-SCZ × BW interaction, along with 
main effects terms, were also used to test for potential interactional effects on cortical 
structure.  
 
3. Results 
3.1 Demographics 
Statistical analyses were conducted to determine if any of the demographic variables were 
associated with PGRS-SCZ at threshold P ≤ 0.1 (see Table 1). No significant associations 
were found (P > 0.05). 
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------------------------------------------------ 
Insert Table 1 here 
------------------------------------------------ 
 
 
 
3.2 Associations Between PGRS-SCZ and Cortical Structure 
Results for PGRS-SCZ × hemisphere interactions on cortical structure can be found in 
Supplementary Material (Table S2-4). No significant hemisphere interactions were found 
in the current study (P > 0.05) thus all analyses were conducted utilising the aforementioned 
repeated measure design. 
 
Significant negative associations between PGRS-SCZ and global CT (β = -.043, p = .012, R2 
= .002) and CV (β = -.033, p = .039, R2 = .001) were found, in that a higher PGRS-SCZ was 
associated with lower CT and CV across the whole brain. However, only the association with 
CT remained significant after multiple correction across all three metrics (CT p(FDR) = .036, 
CV p(FDR) = .059). PGRS-SCZ was also negatively associated with insular lobe CT (β = -.050, 
p(FDR) = .025, R2 = .002).  
 
No significant associations between PGRS-SCZ and SA were found; this was true for all 
global, lobar and parcellation measures, see Supplementary Material. 
 
 
3.3 Associations Between PGRS-SCZ and Birth Weight There was no significant 
association between PGRS-SCZ and birth weight (see Table 2). 
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------------------------------------------------ 
Insert Table 2 here 
------------------------------------------------ 
 
 
 
 
 
3.4 Effects of Interactions Between Birth Weight and PGRS-SCZ on Cortical Structure No 
significant interactions between birth weight and PGRS-SCZ were found with respect to 
associations with global CV or CT. See Table S6-8 in Supplementary Materials for full 
results. 
 
4. Discussion 
We report an association between an increased genetic liability for developing schizophrenia 
and lower global CT and CV, as well as insular lobe CT. In this and previous studies (54, 88) 
we primarily test and report corrected results using SNPs with P ≤ 0.1. We also include 
results corrected over all three cortical metrics to illustrate the effects of more stringent 
control for multiple comparisons, and note that the association between PGRS-SCZ and 
global CV was not significant after this correction. This is one of the first studies to analyse 
associations for CV, CT and SA measures within a single large, population-based sample, 
and to examine the association between these parameters and PGRS-SCZ. Overall, these 
results suggest that lower CT, commonly reported in schizophrenia patients, may be driven 
by a genetic liability for schizophrenia and are most likely not due to factors downstream of 
disease onset (e.g. medication use (89)).  No significant associations were found for SA. 
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Previous study of associations between PGRS-SCZ and brain volume have been inconsistent. 
Lee et al. (90) found ICV to be significantly linked with enrichment of schizophrenia-
associated genetic variants but could not determine the direction of these effects. Another 
study, utilising a PGRS-SCZ created from the first PGC-SCZ GWAS (91) found an 
association between decreased total brain volume and higher PGRS-SCZ (49) but attempts to 
replicate these results, with the most recent PGC-SCZ GWAS findings (5), have so far been 
unsuccessful (52, 53). However, the sample sizes used within these studies are relatively 
small (nindividuals range =122-763). This is especially pertinent when considering that, despite 
the current sample being much larger (nindividuals =2,864) than these previous studies, our CV 
result did not survive FDR corrections for multiple comparisons over all three cortical 
metrics. Thus, further testing in an even larger population-based samples is desirable. 
 
The global CT association is consistent with previous familial high-risk studies for 
schizophrenia, which also found thinning in widespread areas of the cortex both 
longitudinally (42, 44, 47) and cross-sectionally (21, 40, 41, 43). A genetic enrichment study 
also found several CT parcels to be associated with schizophrenia risk variants (90). 
Furthermore, a case-control study found that a higher PGRS-SCZ was associated with lower 
global CT in both the schizophrenia patient only analysis and in the whole sample (54). 
Specific links between reduced insular CT and genetic risk for schizophrenia have been less 
commonly reported, although reductions in this region, among others, have been found in 
schizophrenia patients compared to controls and individuals at genetic high-risk of the 
disorder (41). Additionally, the insula is a region commonly reported to be involved in 
schizophrenia symptomatology (e.g. auditory hallucinations (92)). 
 
That no PGRS-SCZ associations were found for SA is not entirely surprising. Evidence of 
SA abnormalities associated with schizophrenia has been inconsistent (24) and has been 
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described as a ‘weak intermediate phenotype’ for schizophrenia (20). However, evidence 
does suggest that this phenotype is highly heritable (15) and is associated with some deficits 
in the healthy relatives of schizophrenia patients (21). A general limitation of PGRS, at 
present, is that the amount of phenotypic variation that they explain is far smaller than the 
heritability of the phenotype (48, 93); thus, it may be that the predictive power of PGRS-SCZ 
in combination with the current sample size are not large enough to detect an effect with SA.  
 
No association was found between PGRS-SCZ and birth weight, nor were there interaction 
effects between these two factors within global CT.  As previous studies have found lower 
birth weight to be associated with lower CV (66-68), thinning and thickening across the 
cortex (67, 94), an increased risk of schizophrenia (60-62) and several independent SNPs (95, 
96); we expected to find a link between these factors. However, the current findings suggest 
that genetic variants for schizophrenia and birth weight could have independent effects on 
CT. Further investigation is needed to determine this.  
 
4.1 Strengths and Limitations 
The main limitation of the current study and PGRS-SCZ studies in general, is that, at present, 
the variance of schizophrenia explained by PGRS is relatively small (around 2-3% (3)) and 
that larger sample sizes could significantly increase the power of this method (97). Despite 
this study being the largest imaging PGRS study to date, with 2,864 individuals (48, 49, 52, 
53), it is still relatively small compared to other PGRS studies (e.g. (98-100)). Furthermore, a 
post-hoc analysis (see Supplementary Material) suggests that the current study was 
underpowered (5-41%) for some analyses, highlighting the need for even larger imaging 
samples. Current calculations suggest a sample of at least ~21,500 to reliably detect some 
effects of current PGRS-SCZ on cortical structure. Given UKB’s goal of acquiring 100,000 
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scans by 2022 (https://imaging.ukbiobank.ac.uk/), we should be able to improve our sample 
size in the near future. This sample size, coupled with larger discovery GWAS, will allow for 
detection of smaller effects (48, 101, 102) and may eventually allow PGRS to be used in the 
development of personalised medicine (101) however, further research would be necessary. 
A further limitation, related to the derivation of the PGRS-SCZ, is that we were unable to 
remove any individuals utilised in the discovery dataset for the PGC schizophrenia working 
group that may also be included in the current UKB sample, as this information is not 
currently available. However, due to the methodological efforts made to overcome this issue 
(e.g. exclusion of schizophrenia cases and IDs from the PGC MDD group) we believe this 
limitation to be relatively minor as effects will be restricted to controls only. 
 
Although multi-centre collaborations have made larger samples more achievable, different 
acquisition protocols could lead to variability in image contrast and, in turn, discordance over 
brain segmentation between sites; necessitating the development of reliable acquisition 
protocols to attempt to reduce such issues (35, 103). A strength of the current study is that all 
brain images were collected on a single scanner using the same protocol and analysis pipeline 
thus, by-passing multi-scanner variability problems and the need to assess reliability. 
Furthermore, as UKB is a population-based sample and all schizophrenia cases were 
excluded, we are also able to test for associations whilst avoiding confounds such as 
secondary effects of illness or antipsychotic medication use (89). 
 
Previous studies have reported that individuals at familial high-risk, who developed 
schizophrenia, have significantly higher PGRS-SCZ than those at high-risk who remained 
well and that these PGRS are positively associated with gyral folding (88). It is possible that 
there are different genetic associations for different brain measures than derived for in the 
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current study. Given the current sample consisted of older individuals (46-78 years, mean = 
62.3), compared to most schizophrenia studies (49, 50, 52, 53, 104), which commonly 
include age ranges that more closely map to age of disorder onset (18-55 years), we cannot 
rule out effects of ageing on the current results. Further investigation in prospective case-
control samples is required. 
 
Although the inclusion of birth weight, a proxy for OCs and risk factor for schizophrenia 
which is influenced by both genetic and environmental factors (60-62, 65), is a strength of the 
current paper, we cannot rule out environmental effects on our current findings. For example, 
both cannabis use and developmental trauma have been linked with reductions in CT (105) 
and an accumulation of environmental risk factors (including migration, cannabis use, 
urbanicity, OCs and adverse events) has been associated with lower temporal CT (54). 
Furthermore, cannabis use has been found to moderate the link between PGRS-SCZ and 
cortical maturation (106). Thus, environmental risk factors should be explored in further 
studies of potential gene-environment interactions on structural brain measures in 
schizophrenia.  
 
5. Conclusion 
In summary, the current finding that lower global CT, as well as insular lobe CT, is 
associated with an increased genetic loading for schizophrenia. This provides further 
evidence that individual differences in CT are, at least partly, influenced by a genetic 
component. Importantly, these findings also suggest that the schizophrenia and CT 
associations, reported here and in previous literature, are most likely not confounded by 
factors downstream of disorder onset (e.g. use of medication).  Furthermore, it suggests that 
using a PGRS approach may help to elucidate the genetic pathophysiology of the disorder, as 
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GWAS and genomic imaging studies get larger they could identify how more specific 
genetic, expression and pathway effects impact upon global and/or particular brain structures, 
connections and networks. Further consideration of environmental risk factors for 
schizophrenia will also be crucial to understanding the nature of the relationship between 
schizophrenia and cortical structure.  
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Tables 
 
 
Table 1. Descriptive statistics for demographic variables and their associations with PGRS-SCZ 
 Mean 
or n 
S.D Range Test statistic, P-
value 
Gender    X2 = 2707.8, p = 
.513 
    Male 1382    
    Female 1482    
Age 62.35 7.40 46 - 78 r = -.003, p = .863 
Birth weight (kg) 3.40 .61 .91 – 5.78 r = -.044, p = .069 .   
Height (cm) 169.73 9.12 143 - 196 r = -.033, p = .077 .  
Townsend Deprivation 
Scale 
-1.98 2.68 -6.26 – 9.16 r = .017, p = .363 
. p
 
≤ .10, X2 = chi-squared, r = Pearson’s correlation 
Mean, standard deviation (S.D) and range of all demographic variables within the current sample as well as test 
statistics for associations with PGRS-SCZ at the P ≤ 0.1 threshold (n = 2.864) 
 
 
 
Table 2. Results for associations between PGRS-SCZ and birth weight at all P thresholds  
PGRS Threshold Effect 
Size 
S.D P-value p(FDR) 
P ≤ 0.01 
-0.016 0.024 0.513 0.513 
P ≤ 0.05 
-0.037 0.024 0.122 0.305 
P ≤ 0.1 
-0.041 0.024 0.090 0.305 
P ≤ 0.5 -0.021 0.024 0.380 0.513 
P ≤ 1 
-0.019 0.024 0.423 0.513 
Standardised Betas (Effect Size), standard deviations (S.D) and P-values for all associations as well as FDR 
corrected P-values (p(FDR)) over all five PGRS SNP inclusion thresholds (n = 1,659) 
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Impact of Polygenic Risk for Schizophrenia on Cortical  
Structure in UK Biobank 
 
Supplementary Information 
 
Supplemental Methods 
1.1 Participants  
Detailed participant information has been reported previously (1-3) 
(http://www.ukbiobank.ac.uk/participants/).  The flow chart below (Fig S1) clearly outlines how the 
UK Biobank sample was manipulated in order to arrive at a final sample for conducting the current 
analyses. Briefly, participants were recruited as part of the UK Biobank study which consists of 501,726 
participants from Great Britain assessed between 2006 and 2010 and aged between 40 and 69 years 
(http://www.ukbiobank.ac.uk). Around four years after initial recruitment, a subset of this sample 
underwent MRI. The current study includes the first release of cortical data from UK Biobank, using 
global, lobar and regional values for cortical volume, surface area and thickness (n = 3,875). At the time 
of scan, along with two other time points, BW information was also collected. 488,377 UK Biobank 
individuals had genome-wide genotyped data available. Complete data comprising genetic and cortical 
information were available for 2,971 individuals. Those who were part of multiple births were removed 
(n = 2,873). Additionally, global cortical outliers (±3 SDs) were excluded as in previous publications 
(4, 5) (n = 2,864). 
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Fig S1. PGRS Imaging Sample. Flow chart outlining exclusion criteria used to arrive at final UK 
Biobank sample for analysis 
 
1.2 MRI Analysis  
Measures of cortical thickness (mm), surface area (mm2) and volume (mm3) were calculated for the 
current study. Cortical thickness was computed in FreeSurfer by calculating the closest distance from 
the gray/white matter boundary and the gray/CSF boundary at each vertex on the tessellated surface 
and is averaged over all vertices (6). Cortical surface area was calculated by summing the area of the 
vertices in each region. Cortical volume was calculated as the product of the cortical thickness and 
surface area (7, 8). Freesurfer Pre-processing Pipeline: The processing stream includes; motion 
correction and averaging (9) of T1 weighted images, exclusion of non-brain tissue using a hybrid 
watershed/surface deformation procedure, automated Talairach transformation, intensity normalisation 
(10), tessellation of the grey matter/white matter boundary, automated topology correction (11, 12) and 
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surface deformation to most accurately place the grey/white and grey/cerebrospinal fluid borders (10). 
On completion of the cortical models, a number of deformable procedures can be performed in further 
data processing and analysis, including surface inflation (6), parcellation of the cortex into units with 
respect to gyral and sulcal structure (13) and creation of a variety of surface based data. Both intensity 
and continuity information from the whole three-dimensional magnetic resonance volume in 
segmentation and deformation procedures are used in this method, in order to produce representations 
of cortical thickness calculated as the closest distance from the gray/white matter boundary and the 
gray/CSF boundary at each vertex on the tessellated surface (9). Maps are created using spatial intensity 
gradients across tissue classes thus, do not depend on absolute signal intensity. The procedure for 
cortical thickness measurement has been validated against histological analysis (6) and manual 
measurements (14). Designation of Cortical Regions: Of the 34 regions parcellated by FreeSurfer, the 
23 that were used as they were are: Frontal pole, medial orbitofrontal, lateral orbitofrontal, caudal 
middle frontal, insula, precentral, postcentral, paracentral, rostral anterior cingulate, caudal anterior 
cingulate, posterior cingulate, isthmus, temporal pole, middle temporal, inferior temporal, 
parahippocampal, entorhinal, fusiform, supramarginal, superior parietal, inferior parietal, precuneus, 
lateral occipital. The 11 parcels that were combined to make larger regions are as follows: Superior 
Temporal Gyrus (STG) = banks of the superior temporal sulcus, transverse temporal, superior temporal; 
Inferior Frontal Gyrus (IFG) = pars opercularis, pars triangularis, pars orbitalis; Dorsal Lateral 
Prefrontal Cortex (DLPFC) = rostral middle frontal, superior frontal; Medial Occipital (MO) = 
pericalcarine, cuneus, lingual. Fig S2 (below) shows these combined regions on the Desikan-Killiany 
atlas. 
 
Fig S2. Combined Parcellations. Figure showing the combined regions (listed above) on the Desikan-
Killiany atlas. Adapted from Desikan et al. (13). 
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Regions were attributed to lobes using the standard ‘lobes’ definition of the mri_annotation2lable 
command (https://surfer.nmr.mgh.harvard.edu/fswiki/mri_annotation2label). The attribution of these 
parcellated regions to lobes are as follows: Frontal lobe –DLPFC, Caudal middle frontal gyrus, IFG, 
Lateral and Medial orbitofrontal cortex, Frontal pole, Precentral gyrus; Temporal lobe – Entorhinal 
cortex, Parahippocampal gyrus, Temporal pole, Fusiform gyrus and STG; Occipital Lobe – MO and 
Lateral occipital cortex; Parietal lobe – Superior Parietal cortex, Inferior Parietal cortex, Supramarginal 
gyrus, Precuneus cortex; Cingulate cortex – Rostral anterior cingulate, Caudal anterior cingulate, 
Posterior Cingulate, Isthmus division; Insular lobe - Insula; Postcentral lobule – Postcentral gyrus; 
Paracentral lobule – Paracentral lobule (13). 
 
1.3 MRI Quality Control Procedures  
Images were visually assessed for major errors (e.g. zero or partial output, substantial skull strip issues 
or tissue identification issues) which removed 458 scans, see Supplementary Fig S1. The remaining 
3,875 scans were then assessed for minor errors (e.g. erroneous boundary placement, minor skull 
stripping issues and minor tissue omission) which resulted in removal of individual regions within scans 
(6,192 of the possible 295,052 regions were removed).  As global information was largely unaffected 
by the FreeSurfer reconstruction process, global and lobar values were extracted from the data with 
major errors removed but did not undergo QC exclusion for minor errors. However, exclusion of global 
cortical outliers (±3 SDs) provided a further internal imaging QC as in previous publications (4, 5). 
 
1.4 Genotyping  
For detailed information on all genotyping procedures please refer to (15, 16). As mentioned in the 
main text, 488,377 blood samples were assayed using two different genotyping arrays; Applied 
Biosystems UK BiLEVE Axiom Array by Affymetrix (15) and Applied Biosystems UK Biobank 
Axiom Array (http://www.ukbiobank.ac.uk/wp-content/uploads/2014/04/UK-Biobank-Axiom-Array-
Content-Summary-2014.pdf). Both arrays were designed for the UK Biobank project and are similar, 
sharing 95% marker content. Pre-phasing was carried out using SHPAEIT3 (17) with the 1000 Genome 
Phase 3 dataset as a reference panel. IMPUTE4 (16) was used for imputation.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Neilson et al.  Supplement 
5 
1.5 Derivation of Polygenic Risk Score  
The Major Histocompatibility Complex region was not excluded in the current analysis. The number 
of SNPs included in each of the five thresholds before LD pruning was as follows: P ≤ 0.01 – 428,741; 
P ≤ 0.05 – 1,084,993; P ≤ 0.1 – 1,701,982; P ≤ 0.5 – 5,422,836; P ≤ 1 – 9,444,231. The final number 
of SNPs used in the PGRS-SCZ was as follows: P ≤ 0.01 – 17,336; P ≤ 0.05 – 51,544; P ≤ 0.1 – 86,124; 
P ≤ 0.5 – 289,280; P ≤ 1 – 468,896. 
 
1.6 Measure of Birth Weight  
BW data were collected at initial assessment and at the first repeat assessment 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=20022). As information from both instances were 
comparable (r = .94), the BW variable included data from instance one as default, missing values were 
replaced by instance two data. Furthermore, only individuals who reported to not be part of a multiple 
birth were included (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=1777). 
 
1.7 Covariates  
Socioeconomic Deprivation is a score assigned based on census output regarding their postcode. 
Standing height was collected at initial assessment, first repeat assessment and at time of scan data from 
both instances were comparable (r = .99). As with BW, data from the first instance was used by default 
and missing values at instance one were replaced by data from instance two. Principal components 
(PCs) were used to control for population stratification. Briefly, PCs were calculated by UK Biobank 
with a principal component analysis (PCA) of the population, using the fastPCA algorithm (18) . The 
top 40 PCs were computed using pruned high-quality markers to reduce linkage disequilibrium (LD) 
(19). The first 15 PCs were used in the current analysis. Head Position in Scanner: Scanner table 
position (http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25759) was also available as a measure to 
correct for head positions in the scanner. However, correcting for all four measures in the linear mixed 
regression resulted in high variance inflation (stat), due to collinearity between the X co-ordinate and 
scanner table position (r ~ 0.9). As we were interested in the head rather than table positions, we 
excluded this as a covariate and opted to use X (http://biobank.ctsu.ox.ac.uk/showcase/
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field.cgi?id=25756), Y (http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25757) and Z 
(http://biobank.ctsu.ox.ac.uk/showcase/field.cgi?id=25758) co-ordinates of the centre of the brain mask 
within the scanner. Intracranial Volume (ICV) was a UKB imaging derived phenotype which consisted 
of gray matter + white matter + ventricular cerebral spinal fluid. 
 
Supplemental Results 
2.1 Hemisphere Interactions  
We assessed the interaction of PGRS-SCZ and birthweight on cortical brain structure. As no significant 
hemisphere interactions were found at the P ≤ 0.1 threshold, no regions were analysed as independent 
left and right structures in the main analysis. Indeed, the only significant interaction that was identified, 
for any cortical metric and at any threshold, was posterior cingulate parcel CT at threshold P ≤ 0.01 (β 
= -.104, pcorr = .006). See Table S1 for full results.  
 
Table S1. Results for PGRS-SCZ*hemisphere interactions on cortical brain structure at 
threshold P ≤ 0.1 (n = 2,864) 
Brain Measure Effect Size SD p value p(FDR) 
Cortical Volume 
Global -0.002 0.003 0.467  
Lobes 
Cingulate 0.019 0.016 0.254 0.763 
Frontal 0.001 0.006 0.885 0.885 
Insula -0.008 0.011 0.445 0.777 
Occipital 0.007 0.010 0.486 0.777 
Parietal -0.009 0.008 0.286 0.763 
Postcentral -0.007 0.015 0.643 0.858 
Precentral 0.003 0.012 0.811 0.885 
Temporal -0.008 0.007 0.196 0.763 
Parcellations 
Caudal Anterior Cingulate -0.005 0.033 0.883 0.946 
Caudal Middle Frontal -0.032 0.022 0.154 0.692 
Entorhinal 0.003 0.028 0.924 0.946 
Fusiform -0.023 0.021 0.261 0.704 
Inferior Parietal -0.010 0.022 0.660 0.946 
Inferior Temporal -0.012 0.022 0.566 0.946 
Isthmus 0.011 0.024 0.637 0.946 
Lateral Occipital 0.011 0.020 0.582 0.946 
Lateral Orbitofrontal 0.016 0.018 0.373 0.830 
Medial Orbitofrontal -0.038 0.023 0.108 0.692 
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Brain Measure Effect Size SD p value p(FDR) 
Middle Temporal 0.002 0.020 0.924 0.946 
Parahippocampal -0.042 0.024 0.077 0.691 
Paracentral -0.030 0.025 0.232 0.695 
Postcentral -0.027 0.022 0.216 0.695 
Posterior Cingulate -0.008 0.025 0.745 0.946 
Precentral -0.021 0.017 0.224 0.695 
Precuneus -0.053 0.016 0.001 0.034 
Rostral Anterior Cingulate 0.002 0.028 0.937 0.946 
Superior Parietal 0.002 0.019 0.926 0.946 
Supramarginal 0.051 0.021 0.018 0.245 
Frontal Pole -0.010 0.029 0.726 0.946 
Temporal Pole 0.024 0.029 0.400 0.830 
Insula -0.025 0.017 0.135 0.692 
Superior Temporal Gyrus 0.001 0.018 0.946 0.946 
Inferior Frontal Gyrus 0.014 0.021 0.525 0.946 
DorsoLateral Prefrontal Cortex 0.010 0.012 0.394 0.830 
Medial Occipital 0.004 0.019 0.817 0.946 
Cortical Surface Area 
Global -0.001 0.003 0.825  
Lobes 
Cingulate 0.034 0.015 0.024 0.189 
Frontal -0.001 0.005 0.827 0.827 
Insula -0.010 0.013 0.419 0.670 
Occipital 0.004 0.010 0.709 0.810 
Parietal -0.004 0.008 0.618 0.810 
Postcentral -0.017 0.014 0.225 0.670 
Precentral 0.013 0.013 0.336 0.670 
Temporal -0.006 0.006 0.325 0.670 
Parcellations 
Caudal Anterior Cingulate -0.008 0.503 0.987 0.999 
Caudal Middle Frontal -0.085 1.144 0.941 0.999 
Entorhinal -0.010 0.250 0.967 0.999 
Fusiform -0.108 1.960 0.956 0.999 
Inferior Parietal -0.130 3.354 0.969 0.999 
Inferior Temporal -0.088 1.841 0.962 0.999 
Isthmus 0.009 0.566 0.988 0.999 
Lateral Occipital -0.089 2.721 0.974 0.999 
Lateral Orbitofrontal -0.047 1.391 0.973 0.999 
Medial Orbitofrontal -0.043 0.968 0.964 0.999 
Middle Temporal -0.077 2.152 0.971 0.999 
Parahippocampal -0.031 0.462 0.947 0.999 
Paracentral -0.063 1.034 0.952 0.999 
Postcentral -0.137 2.529 0.957 0.999 
Posterior Cingulate 0.001 0.730 0.999 0.999 
Precentral -0.135 3.006 0.964 0.999 
Precuneus -0.151 2.580 0.953 0.999 
Rostral Anterior Cingulate -0.023 0.551 0.967 0.999 
Superior Parietal -0.140 3.518 0.968 0.999 
Supramarginal -0.050 2.395 0.983 0.999 
Frontal Pole -0.031 0.217 0.887 0.999 
Temporal Pole 0.025 0.292 0.931 0.999 
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Brain Measure Effect Size SD p value p(FDR) 
Insula -0.077 1.384 0.956 0.999 
Superior Temporal Gyrus -0.135 3.088 0.965 0.999 
Inferior Frontal Gyrus -0.071 2.147 0.974 0.999 
DorsoLateral Prefrontal Cortex -0.316 7.634 0.967 0.999 
Medial Occipital -0.189 4.399 0.966 0.999 
Cortical Thickness 
Global -0.007 0.007 0.308  
Lobes 
Cingulate -0.034 0.018 0.058 0.465 
Frontal 0.002 0.008 0.838 0.970 
Insula -0.003 0.017 0.877 0.970 
Occipital 0.000 0.010 0.970 0.970 
Parietal -0.004 0.009 0.626 0.970 
Postcentral 0.010 0.014 0.466 0.970 
Precentral -0.006 0.012 0.608 0.970 
Temporal -0.008 0.010 0.451 0.970 
Parcellations 
Caudal Anterior Cingulate 0.015 0.031 0.624 0.899 
Caudal Middle Frontal -0.027 0.022 0.231 0.653 
Entorhinal -0.020 0.027 0.459 0.774 
Fusiform -0.004 0.022 0.874 0.943 
Inferior Parietal -0.013 0.020 0.527 0.837 
Inferior Temporal 0.006 0.024 0.793 0.899 
Isthmus -0.048 0.027 0.076 0.653 
Lateral Occipital -0.024 0.019 0.218 0.653 
Lateral Orbitofrontal -0.024 0.024 0.314 0.653 
Medial Orbitofrontal -0.041 0.027 0.125 0.653 
Middle Temporal 0.010 0.024 0.681 0.899 
Parahippocampal -0.041 0.024 0.089 0.653 
Paracentral -0.023 0.020 0.260 0.653 
Postcentral 0.007 0.020 0.711 0.899 
Posterior Cingulate -0.073 0.028 0.010 0.258 
Precentral -0.007 0.018 0.703 0.899 
Precuneus -0.023 0.019 0.215 0.653 
Rostral Anterior Cingulate -0.026 0.030 0.388 0.748 
Superior Parietal -0.004 0.017 0.799 0.899 
Supramarginal -0.024 0.022 0.272 0.653 
Frontal Pole 0.022 0.029 0.456 0.774 
Temporal Pole 0.002 0.027 0.938 0.974 
Insula 0.000 0.025 0.998 0.998 
Superior Temporal Gyrus 0.032 0.022 0.150 0.653 
Inferior Frontal Gyrus 0.006 0.021 0.788 0.899 
DorsoLateral Prefrontal Cortex 0.016 0.015 0.295 0.653 
Medial Occipital 0.020 0.020 0.314 0.653 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
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2.2 Associations Between PGRS-SCZ and Cortical Structure 
 
Table S2. Results for associations between PGRS-SCZ and cortical volume at all thresholds (n = 
2,864) 
Cortical Volume Effect Size SD p value p(FDR) 
Global 
Global 0.01 -0.009 0.015 0.565 0.848 
Global 0.05 -0.021 0.016 0.180 0.270 
Global 0.1 -0.033 0.016 0.039* 0.059. 
Global 0.5 -0.025 0.016 0.120 0.180 
Global 1 -0.026 0.016 0.103 0.155 
Lobes 
Cingulate 0.01 0.005 0.012 0.689 0.843 
Cingulate 0.05 0.001 0.012 0.953 0.953 
Cingulate 0.1 -0.004 0.012 0.727 0.877 
Cingulate 0.5 -0.019 0.012 0.122 0.324 
Cingulate 1 -0.017 0.012 0.163 0.434 
Frontal 0.01 -0.011 0.010 0.262 0.786 
Frontal 0.05 -0.015 0.010 0.115 0.236 
Frontal 0.1 -0.015 0.010 0.116 0.276 
Frontal 0.5 -0.013 0.010 0.192 0.385 
Frontal 1 -0.011 0.010 0.263 0.526 
Insula 0.01 -0.002 0.012 0.843 0.843 
Insula 0.05 -0.020 0.013 0.118 0.236 
Insula 0.1 -0.019 0.013 0.138 0.276 
Insula 0.5 -0.011 0.013 0.389 0.572 
Insula 1 -0.011 0.013 0.382 0.611 
Occipital 0.01 0.011 0.012 0.393 0.786 
Occipital 0.05 0.012 0.013 0.350 0.559 
Occipital 0.1 -0.001 0.013 0.949 0.949 
Occipital 0.5 -0.002 0.013 0.852 0.852 
Occipital 1 -0.002 0.013 0.860 0.870 
Parietal 0.01 -0.002 0.010 0.843 0.843 
Parietal 0.05 0.001 0.010 0.909 0.953 
Parietal 0.1 -0.003 0.010 0.736 0.877 
Parietal 0.5 -0.005 0.010 0.638 0.729 
Parietal 1 -0.002 0.010 0.870 0.870 
Postcentral 0.01 -0.006 0.013 0.639 0.843 
Postcentral 0.05 -0.005 0.013 0.674 0.898 
Postcentral 0.1 -0.004 0.013 0.767 0.877 
Postcentral 0.5 -0.010 0.013 0.429 0.572 
Postcentral 1 -0.009 0.013 0.483 0.644 
Precentral 0.01 -0.012 0.013 0.357 0.786 
Precentral 0.05 -0.020 0.013 0.112 0.236 
Precentral 0.1 -0.023 0.013 0.066 0.276 
Precentral 0.5 -0.027 0.013 0.038 0.302 
Precentral 1 -0.025 0.013 0.055 0.428 
Temporal 0.01 -0.022 0.010 0.037 0.298 
Temporal 0.05 -0.017 0.010 0.103 0.236 
Temporal 0.1 -0.019 0.011 0.073 0.276 
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Cortical Volume Effect Size SD p value p(FDR) 
Temporal 0.5 -0.019 0.011 0.077 0.307 
Temporal 1 -0.017 0.011 0.107 0.428 
Parcellations 
Caudal Anterior Cingulate 0.01 -0.011 0.017 0.501 0.800 
Caudal Anterior Cingulate 0.05 -0.020 0.017 0.225 0.570 
Caudal Anterior Cingulate 0.1 -0.021 0.017 0.206 0.731 
Caudal Anterior Cingulate 0.5 -0.040 0.017 0.021 0.341 
Caudal Anterior Cingulate 1 -0.040 0.017 0.021 0.278 
Caudal Middle Frontal 0.01 0.009 0.016 0.563 0.800 
Caudal Middle Frontal 0.05 0.010 0.016 0.539 0.814 
Caudal Middle Frontal 0.1 0.010 0.016 0.551 0.782 
Caudal Middle Frontal 0.5 0.017 0.017 0.317 0.612 
Caudal Middle Frontal 1 0.019 0.017 0.257 0.577 
Entorhinal 0.01 -0.004 0.018 0.803 0.918 
Entorhinal 0.05 0.002 0.018 0.917 0.987 
Entorhinal 0.1 -0.001 0.018 0.940 0.976 
Entorhinal 0.5 0.004 0.018 0.824 0.905 
Entorhinal 1 0.005 0.018 0.795 0.861 
Fusiform 0.01 -0.020 0.015 0.187 0.560 
Fusiform 0.05 -0.009 0.015 0.534 0.814 
Fusiform 0.1 -0.010 0.015 0.505 0.757 
Fusiform 0.5 -0.017 0.016 0.286 0.594 
Fusiform 1 -0.013 0.016 0.399 0.673 
Inferior Parietal 0.01 -0.012 0.015 0.404 0.780 
Inferior Parietal 0.05 2.51×04 0.015 0.987 0.987 
Inferior Parietal 0.1 -0.002 0.015 0.874 0.955 
Inferior Parietal 0.5 -0.012 0.015 0.420 0.667 
Inferior Parietal 1 -0.011 0.016 0.483 0.724 
Inferior Temporal 0.01 -0.026 0.016 0.092 0.545 
Inferior Temporal 0.05 -0.019 0.016 0.232 0.570 
Inferior Temporal 0.1 -0.020 0.016 0.211 0.731 
Inferior Temporal 0.5 -0.020 0.016 0.203 0.498 
Inferior Temporal 1 -0.023 0.016 0.151 0.471 
Isthmus 0.01 0.022 0.016 0.162 0.545 
Isthmus 0.05 0.023 0.016 0.155 0.570 
Isthmus 0.1 0.016 0.016 0.312 0.731 
Isthmus 0.5 0.008 0.016 0.614 0.824 
Isthmus 1 0.009 0.016 0.600 0.804 
Lateral Occipital 0.01 0.017 0.015 0.261 0.704 
Lateral Occipital 0.05 0.020 0.015 0.181 0.570 
Lateral Occipital 0.1 0.008 0.015 0.614 0.789 
Lateral Occipital 0.5 0.003 0.016 0.872 0.905 
Lateral Occipital 1 0.004 0.016 0.797 0.861 
Lateral Orbitofrontal 0.01 -0.002 0.015 0.912 0.918 
Lateral Orbitofrontal 0.05 -0.006 0.015 0.711 0.959 
Lateral Orbitofrontal 0.1 -0.015 0.015 0.317 0.731 
Lateral Orbitofrontal 0.5 -0.021 0.016 0.173 0.498 
Lateral Orbitofrontal 1 -0.022 0.016 0.171 0.471 
Medial Orbitofrontal 0.01 -0.021 0.015 0.154 0.545 
Medial Orbitofrontal 0.05 -0.018 0.015 0.224 0.570 
Medial Orbitofrontal 0.1 -0.010 0.015 0.497 0.757 
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Medial Orbitofrontal 0.5 -0.009 0.015 0.550 0.802 
Medial Orbitofrontal 1 -0.009 0.016 0.571 0.804 
Middle Temporal 0.01 -0.007 0.015 0.645 0.841 
Middle Temporal 0.05 -0.003 0.015 0.867 0.987 
Middle Temporal 0.1 -0.013 0.015 0.406 0.731 
Middle Temporal 0.5 -0.007 0.015 0.642 0.824 
Middle Temporal 1 -0.007 0.015 0.652 0.804 
Parahippocampal 0.01 0.011 0.018 0.547 0.800 
Parahippocampal 0.05 0.005 0.018 0.794 0.987 
Parahippocampal 0.1 0.001 0.018 0.977 0.977 
Parahippocampal 0.5 0.007 0.018 0.702 0.824 
Parahippocampal 1 0.007 0.018 0.685 0.804 
Paracentral 0.01 -0.015 0.017 0.361 0.750 
Paracentral 0.05 -0.013 0.017 0.426 0.793 
Paracentral 0.1 -0.006 0.017 0.745 0.875 
Paracentral 0.5 0.001 0.017 0.962 0.962 
Paracentral 1 0.001 0.017 0.958 0.974 
Postcentral 0.01 -0.004 0.016 0.817 0.918 
Postcentral 0.05 -0.004 0.016 0.822 0.987 
Postcentral 0.1 -0.002 0.016 0.884 0.955 
Postcentral 0.5 -0.013 0.016 0.409 0.667 
Postcentral 1 -0.014 0.016 0.397 0.673 
Posterior Cingulate 0.01 -0.016 0.016 0.309 0.704 
Posterior Cingulate 0.05 -0.013 0.016 0.429 0.793 
Posterior Cingulate 0.1 -0.014 0.016 0.379 0.731 
Posterior Cingulate 0.5 -0.027 0.017 0.108 0.498 
Posterior Cingulate 1 -0.023 0.017 0.175 0.471 
Precentral 0.01 -0.009 0.015 0.558 0.800 
Precentral 0.05 -0.012 0.015 0.441 0.793 
Precentral 0.1 -0.019 0.015 0.218 0.731 
Precentral 0.5 -0.024 0.016 0.128 0.498 
Precentral 1 -0.023 0.016 0.149 0.471 
Precuneus 0.01 0.023 0.014 0.090 0.545 
Precuneus 0.05 0.021 0.014 0.129 0.570 
Precuneus 0.1 0.019 0.014 0.167 0.731 
Precuneus 0.5 0.013 0.014 0.360 0.647 
Precuneus 1 0.014 0.014 0.333 0.641 
Rostral Anterior Cingulate 0.01 -0.007 0.016 0.654 0.841 
Rostral Anterior Cingulate 0.05 -0.017 0.016 0.303 0.681 
Rostral Anterior Cingulate 0.1 -0.025 0.017 0.135 0.731 
Rostral Anterior Cingulate 0.5 -0.028 0.017 0.100 0.498 
Rostral Anterior Cingulate 1 -0.030 0.017 0.078 0.471 
Superior Parietal 0.01 0.024 0.016 0.130 0.545 
Superior Parietal 0.05 0.020 0.016 0.197 0.570 
Superior Parietal 0.1 0.018 0.016 0.245 0.731 
Superior Parietal 0.5 0.021 0.016 0.187 0.498 
Superior Parietal 1 0.025 0.016 0.118 0.471 
Supramarginal 0.01 -0.003 0.015 0.838 0.918 
Supramarginal 0.05 -0.006 0.015 0.689 0.959 
Supramarginal 0.1 -0.008 0.015 0.610 0.789 
Supramarginal 0.5 -0.006 0.015 0.679 0.824 
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Supramarginal 1 -0.006 0.015 0.677 0.804 
Frontal Pole 0.01 -0.030 0.019 0.115 0.545 
Frontal Pole 0.05 -0.031 0.019 0.104 0.570 
Frontal Pole 0.1 -0.027 0.019 0.162 0.731 
Frontal Pole 0.5 -0.032 0.019 0.102 0.498 
Frontal Pole 1 -0.035 0.020 0.077 0.471 
Temporal Pole 0.01 0.027 0.019 0.155 0.545 
Temporal Pole 0.05 0.029 0.019 0.138 0.570 
Temporal Pole 0.1 0.016 0.019 0.405 0.731 
Temporal Pole 0.5 0.004 0.020 0.848 0.905 
Temporal Pole 1 0.001 0.020 0.974 0.974 
Insula 0.01 -0.009 0.015 0.526 0.800 
Insula 0.05 -0.027 0.015 0.074 0.570 
Insula 0.1 -0.030 0.015 0.046 0.625 
Insula 0.5 -0.023 0.015 0.129 0.498 
Insula 1 -0.024 0.015 0.108 0.471 
Superior Temporal Gyrus 0.01 -0.014 0.014 0.313 0.704 
Superior Temporal Gyrus 0.05 -0.009 0.014 0.543 0.814 
Superior Temporal Gyrus 0.1 -0.013 0.014 0.377 0.731 
Superior Temporal Gyrus 0.5 -0.017 0.015 0.249 0.560 
Superior Temporal Gyrus 1 -0.014 0.015 0.323 0.641 
Inferior Frontal Gyrus 0.01 -0.030 0.016 0.057 0.545 
Inferior Frontal Gyrus 0.05 -0.032 0.016 0.047 0.570 
Inferior Frontal Gyrus 0.1 -0.043 0.016 0.007 0.189 
Inferior Frontal Gyrus 0.5 -0.036 0.016 0.025 0.341 
Inferior Frontal Gyrus 1 -0.038 0.016 0.019 0.278 
DorsoLateral Prefrontal Cortex 0.01 -0.002 0.012 0.867 0.918 
DorsoLateral Prefrontal Cortex 0.05 0.001 0.012 0.920 0.987 
DorsoLateral Prefrontal Cortex 0.1 0.004 0.012 0.721 0.875 
DorsoLateral Prefrontal Cortex 0.5 0.007 0.012 0.565 0.802 
DorsoLateral Prefrontal Cortex 1 0.008 0.012 0.480 0.724 
Medial Occipital 0.01 0.002 0.016 0.918 0.918 
Medial Occipital 0.05 -0.001 0.017 0.969 0.987 
Medial Occipital 0.1 -0.012 0.017 0.461 0.757 
Medial Occipital 0.5 -0.022 0.017 0.196 0.498 
Medial Occipital 1 -0.020 0.017 0.236 0.577 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
Table S3. Results for associations between PGRS-SCZ and cortical surface area at all thresholds 
(n = 2,864) 
Cortical Surface Area Effect Size SD p value p(FDR) 
Global 
Global 0.01 0.002 0.015 0.901 0.901 
Global 0.05 -0.006 0.015 0.678 0.678 
Global 0.1 -0.014 0.015 0.368 0.368 
Global 0.5 -0.004 0.016 0.820 0.820 
Global 1 -0.006 0.016 0.724 0.724 
Lobes 
Cingulate 0.01 0.013 0.011 0.226 0.602 
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Cingulate 0.05 0.016 0.011 0.142 0.555 
Cingulate 0.1 0.013 0.011 0.242 0.862 
Cingulate 0.5 0.006 0.011 0.560 0.896 
Cingulate 1 0.009 0.011 0.429 0.768 
Frontal 0.01 0.002 0.009 0.859 0.859 
Frontal 0.05 0.005 0.009 0.554 0.741 
Frontal 0.1 0.008 0.009 0.357 0.862 
Frontal 0.5 0.014 0.009 0.117 0.468 
Frontal 1 0.017 0.009 0.068 0.273 
Insula 0.01 0.011 0.012 0.357 0.651 
Insula 0.05 0.003 0.012 0.822 0.822 
Insula 0.1 0.009 0.012 0.473 0.862 
Insula 0.5 0.011 0.012 0.361 0.896 
Insula 1 0.010 0.012 0.411 0.768 
Occipital 0.01 0.008 0.013 0.526 0.651 
Occipital 0.05 0.016 0.013 0.208 0.555 
Occipital 0.1 0.008 0.013 0.539 0.862 
Occipital 0.5 0.009 0.013 0.501 0.896 
Occipital 1 0.009 0.013 0.480 0.768 
Parietal 0.01 0.017 0.010 0.083 0.602 
Parietal 0.05 0.019 0.010 0.046 0.367 
Parietal 0.1 0.019 0.010 0.054 0.430 
Parietal 0.5 0.019 0.010 0.051 0.409 
Parietal 1 0.020 0.010 0.039 0.273 
Postcentral 0.01 0.009 0.012 0.433 0.651 
Postcentral 0.05 0.005 0.012 0.649 0.741 
Postcentral 0.1 0.004 0.012 0.754 0.862 
Postcentral 0.5 -0.003 0.012 0.808 0.923 
Postcentral 1 -0.003 0.012 0.800 0.952 
Precentral 0.01 -0.006 0.011 0.570 0.651 
Precentral 0.05 -0.012 0.011 0.297 0.594 
Precentral 0.1 -0.005 0.011 0.674 0.862 
Precentral 0.5 3.52×04 0.012 0.976 0.976 
Precentral 1 -0.002 0.012 0.840 0.952 
Temporal 0.01 -0.013 0.009 0.159 0.602 
Temporal 0.05 -0.005 0.009 0.580 0.741 
Temporal 0.1 -3.87×04 0.009 0.967 0.000 
Temporal 0.5 -0.002 0.010 0.798 0.923 
Temporal 1 -0.001 0.010 0.952 0.952 
Parcellations 
Caudal Anterior Cingulate 0.01 0.032 0.254 0.900 0.978 
Caudal Anterior Cingulate 0.05 0.030 0.257 0.908 0.981 
Caudal Anterior Cingulate 0.1 0.053 0.259 0.839 0.909 
Caudal Anterior Cingulate 0.5 0.044 0.262 0.866 0.900 
Caudal Anterior Cingulate 1 0.044 0.263 0.868 0.902 
Caudal Middle Frontal 0.01 0.104 0.578 0.857 0.978 
Caudal Middle Frontal 0.05 0.109 0.584 0.853 0.981 
Caudal Middle Frontal 0.1 0.152 0.588 0.796 0.909 
Caudal Middle Frontal 0.5 0.166 0.597 0.781 0.900 
Caudal Middle Frontal 1 0.163 0.599 0.785 0.902 
Entorhinal 0.01 0.003 0.126 0.978 0.978 
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Entorhinal 0.05 0.011 0.128 0.931 0.981 
Entorhinal 0.1 0.020 0.129 0.875 0.909 
Entorhinal 0.5 0.027 0.131 0.839 0.900 
Entorhinal 1 0.026 0.131 0.842 0.902 
Fusiform 0.01 0.130 0.990 0.896 0.978 
Fusiform 0.05 0.140 1.001 0.889 0.981 
Fusiform 0.1 0.217 1.008 0.829 0.909 
Fusiform 0.5 0.219 1.023 0.831 0.900 
Fusiform 1 0.215 1.026 0.834 0.902 
Inferior Parietal 0.01 0.261 1.693 0.878 0.978 
Inferior Parietal 0.05 0.269 1.712 0.875 0.981 
Inferior Parietal 0.1 0.395 1.724 0.819 0.909 
Inferior Parietal 0.5 0.408 1.750 0.816 0.900 
Inferior Parietal 1 0.397 1.755 0.821 0.902 
Inferior Temporal 0.01 0.108 0.929 0.908 0.978 
Inferior Temporal 0.05 0.118 0.939 0.900 0.981 
Inferior Temporal 0.1 0.190 0.946 0.841 0.909 
Inferior Temporal 0.5 0.198 0.960 0.836 0.900 
Inferior Temporal 1 0.191 0.963 0.843 0.902 
Isthmus 0.01 0.076 0.286 0.792 0.978 
Isthmus 0.05 0.078 0.289 0.788 0.981 
Isthmus 0.1 0.095 0.291 0.744 0.909 
Isthmus 0.5 0.097 0.295 0.744 0.900 
Isthmus 1 0.094 0.296 0.751 0.902 
Lateral Occipital 0.01 0.235 1.374 0.864 0.978 
Lateral Occipital 0.05 0.243 1.389 0.861 0.981 
Lateral Occipital 0.1 0.335 1.399 0.811 0.909 
Lateral Occipital 0.5 0.351 1.420 0.805 0.900 
Lateral Occipital 1 0.344 1.424 0.809 0.902 
Lateral Orbitofrontal 0.01 0.116 0.702 0.869 0.978 
Lateral Orbitofrontal 0.05 0.108 0.710 0.879 0.981 
Lateral Orbitofrontal 0.1 0.158 0.715 0.825 0.909 
Lateral Orbitofrontal 0.5 0.164 0.726 0.821 0.900 
Lateral Orbitofrontal 1 0.162 0.728 0.824 0.902 
Medial Orbitofrontal 0.01 0.068 0.489 0.889 0.978 
Medial Orbitofrontal 0.05 0.073 0.494 0.882 0.981 
Medial Orbitofrontal 0.1 0.114 0.498 0.820 0.909 
Medial Orbitofrontal 0.5 0.126 0.505 0.804 0.900 
Medial Orbitofrontal 1 0.126 0.507 0.803 0.902 
Middle Temporal 0.01 0.159 1.086 0.883 0.978 
Middle Temporal 0.05 0.163 1.098 0.882 0.981 
Middle Temporal 0.1 0.240 1.106 0.828 0.909 
Middle Temporal 0.5 0.257 1.123 0.819 0.900 
Middle Temporal 1 0.249 1.126 0.825 0.902 
Parahippocampal 0.01 0.017 0.233 0.943 0.978 
Parahippocampal 0.05 0.016 0.236 0.944 0.981 
Parahippocampal 0.1 0.040 0.237 0.868 0.909 
Parahippocampal 0.5 0.046 0.241 0.848 0.900 
Parahippocampal 1 0.046 0.242 0.848 0.902 
Paracentral 0.01 0.080 0.522 0.878 0.978 
Paracentral 0.05 0.080 0.528 0.880 0.981 
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Paracentral 0.1 0.131 0.532 0.805 0.909 
Paracentral 0.5 0.147 0.539 0.786 0.900 
Paracentral 1 0.143 0.541 0.791 0.902 
Postcentral 0.01 0.208 1.277 0.870 0.978 
Postcentral 0.05 0.205 1.291 0.874 0.981 
Postcentral 0.1 0.292 1.300 0.822 0.909 
Postcentral 0.5 0.298 1.320 0.822 0.900 
Postcentral 1 0.289 1.323 0.827 0.902 
Posterior Cingulate 0.01 0.046 0.369 0.901 0.978 
Posterior Cingulate 0.05 0.055 0.373 0.882 0.981 
Posterior Cingulate 0.1 0.081 0.375 0.830 0.909 
Posterior Cingulate 0.5 0.078 0.381 0.837 0.900 
Posterior Cingulate 1 0.081 0.382 0.833 0.902 
Precentral 0.01 0.234 1.518 0.877 0.978 
Precentral 0.05 0.231 1.534 0.880 0.981 
Precentral 0.1 0.344 1.545 0.824 0.909 
Precentral 0.5 0.362 1.568 0.818 0.900 
Precentral 1 0.351 1.573 0.823 0.902 
Precuneus 0.01 0.222 1.302 0.864 0.978 
Precuneus 0.05 0.214 1.317 0.871 0.981 
Precuneus 0.1 0.308 1.326 0.817 0.909 
Precuneus 0.5 0.320 1.346 0.812 0.900 
Precuneus 1 0.312 1.350 0.817 0.902 
Rostral Anterior Cingulate 0.01 0.046 0.278 0.869 0.978 
Rostral Anterior Cingulate 0.05 0.042 0.281 0.883 0.981 
Rostral Anterior Cingulate 0.1 0.058 0.283 0.837 0.909 
Rostral Anterior Cingulate 0.5 0.063 0.287 0.826 0.900 
Rostral Anterior Cingulate 1 0.060 0.288 0.836 0.902 
Superior Parietal 0.01 0.300 1.776 0.866 0.978 
Superior Parietal 0.05 0.289 1.796 0.872 0.981 
Superior Parietal 0.1 0.420 1.809 0.816 0.909 
Superior Parietal 0.5 0.447 1.836 0.808 0.900 
Superior Parietal 1 0.439 1.841 0.812 0.902 
Supramarginal 0.01 0.194 1.209 0.873 0.978 
Supramarginal 0.05 0.194 1.222 0.874 0.981 
Supramarginal 0.1 0.281 1.231 0.819 0.909 
Supramarginal 0.5 0.296 1.250 0.813 0.900 
Supramarginal 1 0.287 1.253 0.819 0.902 
Frontal Pole 0.01 0.003 0.110 0.978 0.978 
Frontal Pole 0.05 3.09×04 0.111 0.998 0.998 
Frontal Pole 0.1 0.010 0.112 0.930 0.930 
Frontal Pole 0.5 0.002 0.113 0.985 0.985 
Frontal Pole 1 0.003 0.113 0.980 0.980 
Temporal Pole 0.01 0.054 0.148 0.716 0.978 
Temporal Pole 0.05 0.055 0.149 0.713 0.981 
Temporal Pole 0.1 0.065 0.150 0.666 0.909 
Temporal Pole 0.5 0.048 0.153 0.753 0.900 
Temporal Pole 1 0.044 0.153 0.774 0.902 
Insula 0.01 0.116 0.699 0.868 0.978 
Insula 0.05 0.106 0.706 0.881 0.981 
Insula 0.1 0.160 0.711 0.822 0.909 
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Insula 0.5 0.166 0.722 0.818 0.900 
Insula 1 0.159 0.724 0.826 0.902 
Superior Temporal Gyrus 0.01 0.252 1.559 0.872 0.978 
Superior Temporal Gyrus 0.05 0.250 1.576 0.874 0.981 
Superior Temporal Gyrus 0.1 0.361 1.588 0.820 0.909 
Superior Temporal Gyrus 0.5 0.377 1.611 0.815 0.900 
Superior Temporal Gyrus 1 0.368 1.616 0.820 0.902 
Inferior Frontal Gyrus 0.01 0.162 1.084 0.881 0.978 
Inferior Frontal Gyrus 0.05 0.160 1.096 0.884 0.981 
Inferior Frontal Gyrus 0.1 0.233 1.104 0.833 0.909 
Inferior Frontal Gyrus 0.5 0.251 1.120 0.822 0.900 
Inferior Frontal Gyrus 1 0.244 1.124 0.828 0.902 
DorsoLateral Prefrontal Cortex 0.01 0.616 3.854 0.873 0.978 
DorsoLateral Prefrontal Cortex 0.05 0.620 3.896 0.874 0.981 
DorsoLateral Prefrontal Cortex 0.1 0.903 3.924 0.818 0.909 
DorsoLateral Prefrontal Cortex 0.5 0.951 3.983 0.811 0.900 
DorsoLateral Prefrontal Cortex 1 0.929 3.994 0.816 0.902 
Medial Occipital 0.01 0.339 2.221 0.879 0.978 
Medial Occipital 0.05 0.347 2.245 0.877 0.981 
Medial Occipital 0.1 0.498 2.261 0.826 0.909 
Medial Occipital 0.5 0.517 2.295 0.822 0.900 
Medial Occipital 1 0.506 2.302 0.826 0.902 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
 
Table S4. Results for associations between PGRS-SCZ and cortical thickness at all thresholds (n 
= 2,864) 
Cortical Thickness Effect Size SD p value p(FDR) 
Global 
Global 0.01 -0.026 0.017 0.120 0.360 
Global 0.05 -0.036 0.017 0.034* 0.102 
Global 0.1 -0.043 0.017 0.012* 0.036* 
Global 0.5 -0.048 0.017 0.006** 0.018* 
Global 1 -0.044 0.017 0.011* 0.033* 
Lobes 
Cingulate 0.01 -0.024 0.016 0.122 0.219 
Cingulate 0.05 -0.030 0.016 0.055 0.103 
Cingulate 0.1 -0.035 0.016 0.028 0.056 . 
Cingulate 0.5 -0.050 0.016 0.002 0.013* 
Cingulate 1 -0.051 0.016 0.002 0.014* 
Frontal 0.01 -0.020 0.017 0.231 0.308 
Frontal 0.05 -0.033 0.017 0.055 0.103 
Frontal 0.1 -0.040 0.017 0.021 0.056 . 
Frontal 0.5 -0.043 0.018 0.015 0.040* 
Frontal 1 -0.043 0.018 0.015 0.041* 
Insula 0.01 -0.032 0.017 0.055 0.200 
Insula 0.05 -0.042 0.017 0.013 0.103 
Insula 0.1 -0.050 0.017 0.003 0.025* 
Insula 0.5 -0.050 0.017 0.003 0.013* 
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Insula 1 -0.046 0.017 0.008 0.031* 
Occipital 0.01 3.70×04 0.017 0.982 0.982 
Occipital 0.05 -0.011 0.017 0.530 0.538 
Occipital 0.1 -0.017 0.017 0.327 0.373 
Occipital 0.5 -0.018 0.017 0.297 0.337 
Occipital 1 -0.018 0.017 0.311 0.356 
Parietal 0.01 -0.029 0.017 0.075 0.200 
Parietal 0.05 -0.031 0.017 0.064 0.103 
Parietal 0.1 -0.034 0.017 0.042 0.067 
Parietal 0.5 -0.037 0.017 0.030 0.048* 
Parietal 1 -0.033 0.017 0.055 0.087 
Postcentral 0.01 -0.024 0.016 0.137 0.219 
Postcentral 0.05 -0.019 0.017 0.253 0.337 
Postcentral 0.1 -0.013 0.017 0.442 0.442 
Postcentral 0.5 -0.016 0.017 0.337 0.337 
Postcentral 1 -0.014 0.017 0.416 0.416 
Precentral 0.01 -0.005 0.017 0.769 0.879 
Precentral 0.05 -0.010 0.017 0.538 0.538 
Precentral 0.1 -0.024 0.017 0.157 0.209 
Precentral 0.5 -0.035 0.017 0.043 0.057 . 
Precentral 1 -0.028 0.017 0.108 0.144 
Temporal 0.01 -0.036 0.016 0.029 0.200 
Temporal 0.05 -0.034 0.016 0.036 0.103 
Temporal 0.1 -0.040 0.017 0.015 0.056 . 
Temporal 0.5 -0.039 0.017 0.020 0.040* 
Temporal 1 -0.036 0.017 0.032 0.063 
Parcellations 
Caudal Anterior Cingulate 0.01 -0.003 0.018 0.861 0.960 
Caudal Anterior Cingulate 0.05 -0.011 0.018 0.553 0.802 
Caudal Anterior Cingulate 0.1 -0.025 0.019 0.180 0.591 
Caudal Anterior Cingulate 0.5 -0.040 0.019 0.031 0.350 
Caudal Anterior Cingulate 1 -0.042 0.019 0.026 0.321 
Caudal Middle Frontal 0.01 -0.012 0.019 0.527 0.960 
Caudal Middle Frontal 0.05 -0.015 0.019 0.435 0.802 
Caudal Middle Frontal 0.1 -0.023 0.019 0.241 0.591 
Caudal Middle Frontal 0.5 -0.019 0.020 0.343 0.473 
Caudal Middle Frontal 1 -0.016 0.020 0.418 0.631 
Entorhinal 0.01 0.005 0.020 0.791 0.960 
Entorhinal 0.05 0.011 0.020 0.564 0.802 
Entorhinal 0.1 0.007 0.020 0.736 0.736 
Entorhinal 0.5 0.007 0.020 0.715 0.743 
Entorhinal 1 0.009 0.020 0.658 0.711 
Fusiform 0.01 -0.008 0.019 0.661 0.960 
Fusiform 0.05 -0.006 0.019 0.756 0.867 
Fusiform 0.1 -0.017 0.019 0.371 0.660 
Fusiform 0.5 -0.018 0.019 0.350 0.473 
Fusiform 1 -0.013 0.020 0.491 0.631 
Inferior Parietal 0.01 -0.011 0.018 0.554 0.960 
Inferior Parietal 0.05 -0.005 0.018 0.766 0.867 
Inferior Parietal 0.1 -0.009 0.019 0.610 0.686 
Inferior Parietal 0.5 -0.018 0.019 0.345 0.473 
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Inferior Parietal 1 -0.014 0.019 0.471 0.631 
Inferior Temporal 0.01 -0.006 0.019 0.761 0.960 
Inferior Temporal 0.05 -3.31×04 0.019 0.986 0.986 
Inferior Temporal 0.1 -0.011 0.019 0.584 0.685 
Inferior Temporal 0.5 -0.012 0.020 0.557 0.684 
Inferior Temporal 1 -0.010 0.020 0.631 0.710 
Isthmus 0.01 -0.028 0.019 0.134 0.778 
Isthmus 0.05 -0.019 0.019 0.324 0.802 
Isthmus 0.1 -0.026 0.019 0.179 0.591 
Isthmus 0.5 -0.034 0.019 0.080 0.360 
Isthmus 1 -0.032 0.019 0.097 0.414 
Lateral Occipital 0.01 4.15×03 0.019 0.983 0.983 
Lateral Occipital 0.05 -0.003 0.019 0.868 0.938 
Lateral Occipital 0.1 -0.014 0.019 0.484 0.685 
Lateral Occipital 0.5 -0.019 0.020 0.323 0.473 
Lateral Occipital 1 -0.019 0.020 0.334 0.601 
Lateral Orbitofrontal 0.01 -0.016 0.020 0.427 0.960 
Lateral Orbitofrontal 0.05 -0.013 0.020 0.511 0.802 
Lateral Orbitofrontal 0.1 -0.029 0.020 0.152 0.591 
Lateral Orbitofrontal 0.5 -0.029 0.021 0.155 0.442 
Lateral Orbitofrontal 1 -0.032 0.021 0.124 0.419 
Medial Orbitofrontal 0.01 -0.014 0.020 0.477 0.960 
Medial Orbitofrontal 0.05 -0.017 0.020 0.399 0.802 
Medial Orbitofrontal 0.1 -0.019 0.020 0.330 0.640 
Medial Orbitofrontal 0.5 -0.023 0.020 0.260 0.473 
Medial Orbitofrontal 1 -0.026 0.020 0.198 0.518 
Middle Temporal 0.01 -0.002 0.019 0.930 0.966 
Middle Temporal 0.05 -0.005 0.019 0.771 0.867 
Middle Temporal 0.1 -0.020 0.019 0.287 0.640 
Middle Temporal 0.5 -0.016 0.019 0.401 0.516 
Middle Temporal 1 -0.013 0.019 0.487 0.631 
Parahippocampal 0.01 0.018 0.020 0.350 0.960 
Parahippocampal 0.05 0.017 0.020 0.385 0.802 
Parahippocampal 0.1 0.012 0.020 0.556 0.685 
Parahippocampal 0.5 0.021 0.020 0.297 0.473 
Parahippocampal 1 0.021 0.020 0.316 0.601 
Paracentral 0.01 -0.017 0.020 0.389 0.960 
Paracentral 0.05 -0.015 0.020 0.449 0.802 
Paracentral 0.1 -0.020 0.020 0.332 0.640 
Paracentral 0.5 -0.023 0.021 0.265 0.473 
Paracentral 1 -0.022 0.021 0.290 0.601 
Postcentral 0.01 -0.026 0.019 0.173 0.778 
Postcentral 0.05 -0.019 0.020 0.332 0.802 
Postcentral 0.1 -0.012 0.020 0.554 0.685 
Postcentral 0.5 -0.019 0.020 0.344 0.473 
Postcentral 1 -0.018 0.020 0.370 0.624 
Posterior Cingulate 0.01 -0.009 0.019 0.620 0.960 
Posterior Cingulate 0.05 -0.018 0.019 0.339 0.802 
Posterior Cingulate 0.1 -0.023 0.019 0.236 0.591 
Posterior Cingulate 0.5 -0.037 0.019 0.057 0.360 
Posterior Cingulate 1 -0.038 0.019 0.049 0.332 
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Precentral 0.01 0.003 0.020 0.889 0.960 
Precentral 0.05 0.002 0.020 0.917 0.952 
Precentral 0.1 -0.013 0.020 0.511 0.685 
Precentral 0.5 -0.021 0.020 0.307 0.473 
Precentral 1 -0.016 0.020 0.438 0.631 
Precuneus 0.01 0.005 0.019 0.790 0.960 
Precuneus 0.05 0.012 0.019 0.535 0.802 
Precuneus 0.1 0.012 0.020 0.540 0.685 
Precuneus 0.5 0.004 0.020 0.856 0.856 
Precuneus 1 0.005 0.020 0.814 0.814 
Rostral Anterior Cingulate 0.01 -0.016 0.019 0.390 0.960 
Rostral Anterior Cingulate 0.05 -0.019 0.019 0.323 0.802 
Rostral Anterior Cingulate 0.1 -0.027 0.019 0.155 0.591 
Rostral Anterior Cingulate 0.5 -0.032 0.019 0.094 0.363 
Rostral Anterior Cingulate 1 -0.032 0.019 0.096 0.414 
Superior Parietal 0.01 0.003 0.020 0.885 0.960 
Superior Parietal 0.05 0.013 0.020 0.496 0.802 
Superior Parietal 0.1 0.009 0.020 0.652 0.705 
Superior Parietal 0.5 0.008 0.020 0.704 0.743 
Superior Parietal 1 0.011 0.020 0.604 0.709 
Supramarginal 0.01 -0.019 0.019 0.297 0.960 
Supramarginal 0.05 -0.023 0.019 0.222 0.802 
Supramarginal 0.1 -0.027 0.019 0.156 0.591 
Supramarginal 0.5 -0.029 0.019 0.127 0.430 
Supramarginal 1 -0.024 0.019 0.215 0.518 
Frontal Pole 0.01 -0.026 0.019 0.173 0.778 
Frontal Pole 0.05 -0.028 0.019 0.150 0.802 
Frontal Pole 0.1 -0.028 0.019 0.156 0.591 
Frontal Pole 0.5 -0.021 0.020 0.295 0.473 
Frontal Pole 1 -0.024 0.020 0.230 0.518 
Temporal Pole 0.01 0.012 0.020 0.539 0.960 
Temporal Pole 0.05 0.019 0.020 0.351 0.802 
Temporal Pole 0.1 0.007 0.020 0.717 0.736 
Temporal Pole 0.5 0.009 0.020 0.674 0.743 
Temporal Pole 1 0.011 0.020 0.587 0.709 
Insula 0.01 -0.034 0.020 0.085 0.767 
Insula 0.05 -0.045 0.020 0.024 0.653 
Insula 0.1 -0.055 0.020 0.006 0.168 
Insula 0.5 -0.053 0.021 0.011 0.284 
Insula 1 -0.048 0.021 0.021 0.321 
Superior Temporal Gyrus 0.01 -0.036 0.019 0.064 0.767 
Superior Temporal Gyrus 0.05 -0.026 0.019 0.183 0.802 
Superior Temporal Gyrus 0.1 -0.024 0.020 0.217 0.591 
Superior Temporal Gyrus 0.5 -0.035 0.020 0.075 0.360 
Superior Temporal Gyrus 1 -0.032 0.020 0.107 0.414 
Inferior Frontal Gyrus 0.01 -0.038 0.019 0.047 0.767 
Inferior Frontal Gyrus 0.05 -0.035 0.019 0.067 0.802 
Inferior Frontal Gyrus 0.1 -0.047 0.019 0.016 0.211 
Inferior Frontal Gyrus 0.5 -0.041 0.020 0.039 0.350 
Inferior Frontal Gyrus 1 -0.042 0.020 0.036 0.321 
DorsoLateral Prefrontal Cortex 0.01 -0.003 0.019 0.884 0.960 
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DorsoLateral Prefrontal Cortex 0.05 -0.009 0.019 0.651 0.837 
DorsoLateral Prefrontal Cortex 0.1 -0.011 0.019 0.582 0.685 
DorsoLateral Prefrontal Cortex 0.5 -0.007 0.020 0.716 0.743 
DorsoLateral Prefrontal Cortex 1 -0.007 0.020 0.735 0.763 
Medial Occipital 0.01 0.011 0.020 0.583 0.960 
Medial Occipital 0.05 -0.010 0.020 0.610 0.824 
Medial Occipital 0.1 -0.017 0.020 0.391 0.660 
Medial Occipital 0.5 -0.029 0.020 0.164 0.442 
Medial Occipital 1 -0.027 0.021 0.192 0.518 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
 
2.3 Associations Between PGRS-SCZ and Birth Weight 
 
Table S5. Results for PGRS-SCZ*birth weight interactions on cortical brain structure at 
threshold P ≤ 0.1 (n =1,659) 
Brain Measure Effect Size SD p value p(FDR) 
Cortical Volume 
Global -0.004 0.033 0.899  
Lobes 
Cingulate -0.011 0.025 0.662 0.788 
Frontal -0.019 0.021 0.364 0.784 
Insula 0.007 0.028 0.788 0.788 
Occipital 0.015 0.027 0.574 0.788 
Parietal 0.019 0.022 0.392 0.784 
Postcentral 0.043 0.028 0.124 0.631 
Precentral -0.011 0.028 0.698 0.788 
Temporal -0.032 0.023 0.158 0.631 
Parcellations 
Caudal Anterior Cingulate -1.045 1.344 0.437 0.741 
Caudal Middle Frontal 0.854 1.139 0.454 0.741 
Entorhinal 3.872 1.273 0.002 0.066 . 
Fusiform -1.535 1.081 0.156 0.741 
Inferior Parietal 1.507 1.157 0.193 0.741 
Inferior Temporal 0.864 1.111 0.437 0.741 
Isthmus 0.658 1.172 0.574 0.764 
Lateral Occipital -1.996 1.015 0.050 0.671 
Lateral Orbitofrontal -0.774 0.891 0.386 0.741 
Medial Orbitofrontal 1.072 1.196 0.371 0.741 
Middle Temporal -1.006 1.018 0.324 0.741 
Parahippocampal 0.089 1.142 0.938 0.938 
Paracentral -0.258 1.219 0.832 0.883 
Postcentral 0.266 1.124 0.813 0.883 
Posterior Cingulate -0.558 1.291 0.666 0.817 
Precentral 1.127 0.860 0.190 0.741 
Precuneus -0.636 0.837 0.447 0.741 
Rostral Anterior Cingulate 0.466 1.285 0.717 0.842 
Superior Parietal 0.547 0.978 0.576 0.764 
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Supramarginal 0.608 1.139 0.594 0.764 
Frontal Pole -0.605 0.888 0.496 0.744 
Temporal Pole 1.446 1.340 0.281 0.741 
Insula 0.584 0.801 0.467 0.741 
Superior Temporal Gyrus -1.525 0.864 0.078 0.701 
Inferior Frontal Gyrus -0.903 1.050 0.390 0.741 
DorsoLateral Prefrontal Cortex 0.119 0.627 0.850 0.883 
Medial Occipital 0.785 0.936 0.402 0.741 
Cortical Surface Area 
Global -0.029 0.032 0.364  
Lobes 
Cingulate -0.026 0.024 0.269 0.492 
Frontal -0.031 0.019 0.107 0.285 
Insula -0.001 0.026 0.971 0.971 
Occipital -0.003 0.028 0.905 0.971 
Parietal -0.022 0.021 0.307 0.492 
Postcentral 0.022 0.026 0.395 0.527 
Precentral -0.055 0.025 0.029 0.225 
Temporal -0.039 0.021 0.056 0.225 
Parcellations 
Caudal Anterior Cingulate -0.017 0.035 0.629 0.849 
Caudal Middle Frontal -0.028 0.035 0.435 0.765 
Entorhinal -0.019 0.039 0.624 0.849 
Fusiform -0.017 0.032 0.599 0.849 
Inferior Parietal -0.011 0.033 0.744 0.853 
Inferior Temporal -0.052 0.032 0.107 0.564 
Isthmus -0.036 0.034 0.291 0.703 
Lateral Occipital 0.012 0.033 0.717 0.853 
Lateral Orbitofrontal -0.007 0.032 0.822 0.853 
Medial Orbitofrontal -0.009 0.031 0.762 0.853 
Middle Temporal -0.072 0.031 0.022 0.202 
Parahippocampal -0.035 0.035 0.324 0.703 
Paracentral -0.069 0.036 0.052 0.351 
Postcentral 0.014 0.031 0.661 0.850 
Posterior Cingulate -0.031 0.034 0.365 0.703 
Precentral -0.088 0.031 0.004 0.060 
Precuneus 0.003 0.031 0.918 0.918 
Rostral Anterior Cingulate -0.045 0.034 0.192 0.647 
Superior Parietal -0.025 0.034 0.458 0.765 
Supramarginal -0.049 0.032 0.127 0.564 
Frontal Pole -0.041 0.038 0.288 0.703 
Temporal Pole -0.056 0.038 0.146 0.564 
Insula 0.008 0.032 0.793 0.853 
Superior Temporal Gyrus -0.030 0.029 0.307 0.703 
Inferior Frontal Gyrus -0.032 0.034 0.356 0.703 
DorsoLateral Prefrontal Cortex -0.081 0.024 0.001 0.024* 
Medial Occipital 0.026 0.036 0.482 0.765 
Cortical Thickness 
Global 0.051 0.038 0.177  
Lobes 
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Cingulate 0.055 0.035 0.118 0.311 
Frontal 0.024 0.038 0.524 0.699 
Insula 0.013 0.037 0.718 0.820 
Occipital 0.035 0.038 0.348 0.556 
Parietal 0.064 0.037 0.085 0.311 
Postcentral 0.052 0.037 0.155 0.311 
Precentral 0.063 0.038 0.092 0.311 
Temporal -0.001 0.036 0.979 0.979 
Parcellations 
Caudal Anterior Cingulate 0.057 0.041 0.164 0.342 
Caudal Middle Frontal 0.059 0.042 0.165 0.342 
Entorhinal -0.042 0.043 0.336 0.566 
Fusiform 0.019 0.042 0.654 0.803 
Inferior Parietal 0.098 0.041 0.017 0.133 
Inferior Temporal -0.003 0.042 0.940 0.974 
Isthmus 0.096 0.042 0.022 0.133 
Lateral Occipital 0.001 0.042 0.974 0.974 
Lateral Orbitofrontal 0.025 0.044 0.570 0.753 
Medial Orbitofrontal -0.006 0.044 0.894 0.966 
Middle Temporal -0.009 0.042 0.820 0.923 
Parahippocampal -0.024 0.044 0.586 0.753 
Paracentral 0.087 0.044 0.051 0.191 
Postcentral 0.065 0.043 0.131 0.342 
Posterior Cingulate 0.065 0.042 0.119 0.342 
Precentral 0.113 0.043 0.010 0.133 
Precuneus 0.096 0.043 0.025 0.133 
Rostral Anterior Cingulate 0.053 0.041 0.201 0.388 
Superior Parietal 0.106 0.043 0.015 0.133 
Supramarginal 0.087 0.041 0.037 0.165 
Frontal Pole -0.081 0.042 0.057 0.191 
Temporal Pole -0.044 0.044 0.315 0.566 
Insula 0.015 0.044 0.742 0.871 
Superior Temporal Gyrus 0.031 0.043 0.464 0.659 
Inferior Frontal Gyrus 0.037 0.043 0.391 0.587 
DorsoLateral Prefrontal Cortex 0.037 0.042 0.382 0.587 
Medial Occipital 0.065 0.044 0.141 0.342 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
Table S6. Results for PGRS-SCZ*birth weight interactions on cortical volume at all thresholds 
(n = 1,659) 
Cortical Volume Effect Size SD p value p(FDR) 
Global 
Global 0.01  0.013 0.033 0.702 0.970 
Global 0.05 -0.017 0.033 0.595 0.970 
Global 0.1 -0.004 0.033 0.899 0.970 
Global 0.5 0.003 0.033 0.938 0.970 
Global 1 -0.001 0.033 0.979 0.970 
Lobes 
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Cingulate 0.01 -0.004 0.025 0.867 0.915 
Cingulate 0.05 -0.019 0.025 0.452 0.724 
Cingulate 0.1 -0.011 0.025 0.662 0.788 
Cingulate 0.5 -0.002 0.025 0.936 0.936 
Cingulate 1 0.002 0.026 0.940 0.940 
Frontal 0.01 -0.008 0.021 0.694 0.915 
Frontal 0.05 -0.021 0.021 0.303 0.702 
Frontal 0.1 -0.019 0.021 0.364 0.784 
Frontal 0.5 -0.012 0.021 0.558 0.772 
Frontal 1 -0.010 0.021 0.647 0.873 
Insula 0.01 -0.024 0.027 0.374 0.700 
Insula 0.05 -0.015 0.027 0.578 0.750 
Insula 0.1 0.007 0.028 0.788 0.788 
Insula 0.5 0.008 0.028 0.762 0.871 
Insula 1 0.005 0.028 0.854 0.940 
Occipital 0.01 0.021 0.027 0.438 0.700 
Occipital 0.05 0.008 0.027 0.777 0.777 
Occipital 0.1 0.015 0.027 0.574 0.788 
Occipital 0.5 0.018 0.027 0.505 0.772 
Occipital 1 0.012 0.027 0.655 0.873 
Parietal 0.01 0.023 0.022 0.290 0.700 
Parietal 0.05 0.021 0.022 0.345 0.702 
Parietal 0.1 0.019 0.022 0.392 0.784 
Parietal 0.5 0.015 0.022 0.489 0.772 
Parietal 1 0.011 0.022 0.627 0.873 
Postcentral 0.01 0.042 0.028 0.127 0.700 
Postcentral 0.05 0.026 0.027 0.351 0.702 
Postcentral 0.1 0.043 0.028 0.124 0.631 
Postcentral 0.5 0.018 0.028 0.509 0.772 
Postcentral 1 0.018 0.028 0.514 0.873 
Precentral 0.01 0.003 0.028 0.915 0.915 
Precentral 0.05 -0.012 0.028 0.656 0.750 
Precentral 0.1 -0.011 0.028 0.698 0.788 
Precentral 0.5 -0.015 0.028 0.579 0.772 
Precentral 1 -0.018 0.028 0.533 0.873 
Temporal 0.01 -0.021 0.023 0.349 0.700 
Temporal 0.05 -0.035 0.022 0.122 0.702 
Temporal 0.1 -0.032 0.023 0.158 0.631 
Temporal 0.5 -0.023 0.023 0.310 0.772 
Temporal 1 -0.028 0.023 0.229 0.873 
Parcellations 
Caudal Anterior Cingulate 0.01 -1.144 1.145 0.318 0.697 
Caudal Anterior Cingulate 0.05 -1.472 1.241 0.236 0.708 
Caudal Anterior Cingulate 0.1 -1.045 1.344 0.437 0.741 
Caudal Anterior Cingulate 0.5 -1.216 1.273 0.340 0.788 
Caudal Anterior Cingulate 1 -1.251 1.285 0.331 0.807 
Caudal Middle Frontal 0.01 0.189 0.880 0.830 0.933 
Caudal Middle Frontal 0.05 0.594 1.003 0.554 0.787 
Caudal Middle Frontal 0.1 0.854 1.139 0.454 0.741 
Caudal Middle Frontal 0.5 0.653 1.039 0.530 0.788 
Caudal Middle Frontal 1 0.655 1.047 0.532 0.807 
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Entorhinal 0.01 2.998 1.032 0.004 0.102 
Entorhinal 0.05 3.050 1.152 0.008 0.224 
Entorhinal 0.1 3.872 1.273 0.002 0.066 
Entorhinal 0.5 3.469 1.185 0.004 0.096 
Entorhinal 1 3.454 1.196 0.004 0.108 
Fusiform 0.01 -1.369 0.831 0.100 0.697 
Fusiform 0.05 -1.174 0.952 0.218 0.708 
Fusiform 0.1 -1.535 1.081 0.156 0.741 
Fusiform 0.5 -1.266 0.986 0.200 0.770 
Fusiform 1 -1.309 0.993 0.188 0.757 
Inferior Parietal 0.01 0.687 0.887 0.439 0.697 
Inferior Parietal 0.05 1.060 0.966 0.273 0.737 
Inferior Parietal 0.1 1.507 1.157 0.193 0.741 
Inferior Parietal 0.5 1.485 1.037 0.153 0.770 
Inferior Parietal 1 1.491 1.042 0.153 0.757 
Inferior Temporal 0.01 0.876 0.856 0.307 0.697 
Inferior Temporal 0.05 0.510 0.981 0.603 0.799 
Inferior Temporal 0.1 0.864 1.111 0.437 0.741 
Inferior Temporal 0.5 0.562 1.013 0.579 0.788 
Inferior Temporal 1 0.444 1.021 0.664 0.807 
Isthmus 0.01 0.643 0.919 0.484 0.727 
Isthmus 0.05 1.273 1.037 0.220 0.708 
Isthmus 0.1 0.658 1.172 0.574 0.764 
Isthmus 0.5 0.595 1.075 0.580 0.788 
Isthmus 1 0.639 1.084 0.556 0.807 
Lateral Occipital 0.01 -1.645 0.781 0.036 0.480 
Lateral Occipital 0.05 -1.957 0.892 0.029 0.387 
Lateral Occipital 0.1 -1.996 1.015 0.050 0.671 
Lateral Occipital 0.5 -1.884 0.923 0.042 0.562 
Lateral Occipital 1 -1.872 0.930 0.044 0.600 
Lateral Orbitofrontal 0.01 -0.158 0.686 0.818 0.933 
Lateral Orbitofrontal 0.05 0.136 0.785 0.862 0.895 
Lateral Orbitofrontal 0.1 -0.774 0.891 0.386 0.741 
Lateral Orbitofrontal 0.5 -0.313 0.813 0.700 0.788 
Lateral Orbitofrontal 1 -0.320 0.819 0.696 0.807 
Medial Orbitofrontal 0.01 1.199 0.924 0.195 0.697 
Medial Orbitofrontal 0.05 1.429 1.055 0.176 0.708 
Medial Orbitofrontal 0.1 1.072 1.196 0.371 0.741 
Medial Orbitofrontal 0.5 1.451 1.092 0.184 0.770 
Medial Orbitofrontal 1 1.423 1.100 0.196 0.757 
Middle Temporal 0.01 -0.680 0.778 0.382 0.697 
Middle Temporal 0.05 -0.262 0.876 0.765 0.857 
Middle Temporal 0.1 -1.006 1.018 0.324 0.741 
Middle Temporal 0.5 -0.704 0.924 0.447 0.788 
Middle Temporal 1 -0.690 0.930 0.458 0.807 
Parahippocampal 0.01 -0.453 0.903 0.616 0.787 
Parahippocampal 0.05 0.123 1.018 0.904 0.904 
Parahippocampal 0.1 0.089 1.142 0.938 0.938 
Parahippocampal 0.5 0.040 1.052 0.970 0.975 
Parahippocampal 1 0.019 1.060 0.986 0.986 
Paracentral 0.01 -0.893 0.951 0.348 0.697 
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Paracentral 0.05 -0.818 1.075 0.447 0.767 
Paracentral 0.1 -0.258 1.219 0.832 0.883 
Paracentral 0.5 -0.489 1.117 0.662 0.788 
Paracentral 1 -0.548 1.125 0.627 0.807 
Postcentral 0.01 -0.116 0.865 0.894 0.938 
Postcentral 0.05 -0.363 0.986 0.712 0.836 
Postcentral 0.1 0.266 1.124 0.813 0.883 
Postcentral 0.5 -0.165 1.022 0.872 0.942 
Postcentral 1 -0.147 1.030 0.887 0.958 
Posterior Cingulate 0.01 -0.483 1.010 0.633 0.787 
Posterior Cingulate 0.05 -0.723 1.145 0.528 0.787 
Posterior Cingulate 0.1 -0.558 1.291 0.666 0.817 
Posterior Cingulate 0.5 -0.475 1.184 0.689 0.788 
Posterior Cingulate 1 -0.619 1.193 0.604 0.807 
Precentral 0.01 0.745 0.661 0.260 0.697 
Precentral 0.05 1.304 0.755 0.085 0.708 
Precentral 0.1 1.127 0.860 0.190 0.741 
Precentral 0.5 0.918 0.784 0.242 0.788 
Precentral 1 0.952 0.790 0.229 0.772 
Precuneus 0.01 -0.386 0.644 0.549 0.780 
Precuneus 0.05 -0.452 0.737 0.540 0.787 
Precuneus 0.1 -0.636 0.837 0.447 0.741 
Precuneus 0.5 -0.320 0.764 0.675 0.788 
Precuneus 1 -0.278 0.769 0.718 0.807 
Rostral Anterior Cingulate 0.01 0.126 1.029 0.903 0.938 
Rostral Anterior Cingulate 0.05 0.517 1.151 0.654 0.802 
Rostral Anterior Cingulate 0.1 0.466 1.285 0.717 0.842 
Rostral Anterior Cingulate 0.5 0.632 1.190 0.596 0.788 
Rostral Anterior Cingulate 1 0.720 1.199 0.548 0.807 
Superior Parietal 0.01 0.588 0.751 0.434 0.697 
Superior Parietal 0.05 0.226 0.861 0.793 0.857 
Superior Parietal 0.1 0.547 0.978 0.576 0.764 
Superior Parietal 0.5 0.371 0.891 0.677 0.788 
Superior Parietal 1 0.395 0.898 0.660 0.807 
Supramarginal 0.01 1.079 0.876 0.219 0.697 
Supramarginal 0.05 1.027 1.005 0.307 0.754 
Supramarginal 0.1 0.608 1.139 0.594 0.764 
Supramarginal 0.5 0.683 1.039 0.511 0.788 
Supramarginal 1 0.683 1.047 0.514 0.807 
Frontal Pole 0.01 -0.637 0.796 0.424 0.697 
Frontal Pole 0.05 -0.637 0.839 0.448 0.767 
Frontal Pole 0.1 -0.605 0.888 0.496 0.744 
Frontal Pole 0.5 -0.644 0.857 0.452 0.788 
Frontal Pole 1 -0.631 0.866 0.466 0.807 
Temporal Pole 0.01 0.964 1.073 0.370 0.697 
Temporal Pole 0.05 1.144 1.201 0.341 0.767 
Temporal Pole 0.1 1.446 1.340 0.281 0.741 
Temporal Pole 0.5 1.223 1.241 0.325 0.788 
Temporal Pole 1 1.109 1.251 0.376 0.807 
Insula 0.01 -0.031 0.617 0.960 0.960 
Insula 0.05 -0.522 0.699 0.455 0.767 
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Insula 0.1 0.584 0.801 0.467 0.741 
Insula 0.5 -0.023 0.729 0.975 0.975 
Insula 1 -0.024 0.733 0.973 0.986 
Superior Temporal Gyrus 0.01 -0.798 0.664 0.230 0.697 
Superior Temporal Gyrus 0.05 -1.105 0.757 0.145 0.708 
Superior Temporal Gyrus 0.1 -1.525 0.864 0.078 0.701 
Superior Temporal Gyrus 0.5 -1.170 0.786 0.137 0.770 
Superior Temporal Gyrus 1 -1.141 0.792 0.150 0.757 
Inferior Frontal Gyrus 0.01 -0.642 0.806 0.426 0.697 
Inferior Frontal Gyrus 0.05 -0.785 0.923 0.396 0.767 
Inferior Frontal Gyrus 0.1 -0.903 1.050 0.390 0.741 
Inferior Frontal Gyrus 0.5 -0.860 0.956 0.369 0.788 
Inferior Frontal Gyrus 1 -0.816 0.963 0.397 0.807 
DorsoLateral Prefrontal Cortex 0.01 0.224 0.482 0.642 0.787 
DorsoLateral Prefrontal Cortex 0.05 0.272 0.551 0.622 0.799 
DorsoLateral Prefrontal Cortex 0.1 0.119 0.627 0.850 0.883 
DorsoLateral Prefrontal Cortex 0.5 0.274 0.571 0.631 0.788 
DorsoLateral Prefrontal Cortex 1 0.253 0.575 0.660 0.807 
Medial Occipital 0.01 0.794 0.718 0.270 0.697 
Medial Occipital 0.05 1.116 0.817 0.172 0.708 
Medial Occipital 0.1 0.785 0.936 0.402 0.741 
Medial Occipital 0.5 1.332 0.850 0.117 0.770 
Medial Occipital 1 1.466 0.856 0.087 0.757 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
 
Table S7. Results for PGRS-SCZ*birth weight interactions on cortical surface area at all 
thresholds (n =1,659) 
Cortical Surface Area Effect Size SD p value p(FDR) 
Global 
Global 0.01 -0.021 0.032 0.512 0.708 
Global 0.05 -0.048 0.032 0.126 0.630 
Global 0.1 -0.029 0.032 0.364 0.708 
Global 0.5 -0.012 0.032 0.708 0.708 
Global 1 -0.014 0.032 0.656 0.708 
Lobar 
Cingulate 0.01 -0.029 0.024 0.225 0.471 
Cingulate 0.05 -0.038 0.023 0.107 0.214 
Cingulate 0.1 -0.026 0.024 0.269 0.492 
Cingulate 0.5 -0.026 0.024 0.278 0.556 
Cingulate 1 -0.019 0.024 0.423 0.677 
Frontal 0.01 -0.029 0.019 0.128 0.471 
Frontal 0.05 -0.036 0.019 0.059 0.173 
Frontal 0.1 -0.031 0.019 0.107 0.285 
Frontal 0.5 -0.022 0.019 0.260 0.556 
Frontal 1 -0.018 0.019 0.360 0.677 
Insula 0.01 -0.025 0.026 0.340 0.471 
Insula 0.05 -0.015 0.026 0.553 0.632 
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Insula 0.1 -0.001 0.026 0.971 0.971 
Insula 0.5 -0.012 0.026 0.652 0.870 
Insula 1 -0.013 0.026 0.615 0.820 
Occipital 0.01 -0.021 0.028 0.449 0.513 
Occipital 0.05 -0.019 0.028 0.502 0.632 
Occipital 0.1 -0.003 0.028 0.905 0.971 
Occipital 0.5 0.001 0.028 0.963 0.963 
Occipital 1 -1.54×04 0.028 0.996 0.996 
Parietal 0.01 -0.019 0.021 0.353 0.471 
Parietal 0.05 -0.028 0.021 0.176 0.281 
Parietal 0.1 -0.022 0.021 0.307 0.492 
Parietal 0.5 -0.017 0.021 0.405 0.649 
Parietal 1 -0.019 0.021 0.383 0.677 
Postcentral 0.01 0.009 0.025 0.720 0.720 
Postcentral 0.05 0.006 0.025 0.812 0.812 
Postcentral 0.1 0.022 0.026 0.395 0.527 
Postcentral 0.5 0.001 0.025 0.960 0.963 
Postcentral 1 0.001 0.026 0.981 0.996 
Precentral 0.01 -0.025 0.025 0.310 0.471 
Precentral 0.05 -0.046 0.025 0.065 0.173 
Precentral 0.1 -0.055 0.025 0.029 0.225 
Precentral 0.5 -0.055 0.025 0.028 0.227 
Precentral 1 -0.052 0.025 0.040 0.323 
Temporal 0.01 -0.038 0.020 0.063 0.471 
Temporal 0.05 -0.048 0.020 0.019 0.149 
Temporal 0.1 -0.039 0.021 0.056 0.225 
Temporal 0.5 -0.026 0.020 0.208 0.556 
Temporal 1 -0.027 0.021 0.191 0.677 
Parcellations 
Caudal Anterior Cingulate 0.01 -0.002 0.036 0.950 0.986 
Caudal Anterior Cingulate 0.05 -0.017 0.035 0.634 0.894 
Caudal Anterior Cingulate 0.1 -0.017 0.035 0.629 0.849 
Caudal Anterior Cingulate 0.5 0.005 0.035 0.877 0.917 
Caudal Anterior Cingulate 1 0.014 0.036 0.700 0.843 
Caudal Middle Frontal 0.01 -2.67×04 0.036 0.994 0.994 
Caudal Middle Frontal 0.05 -0.040 0.035 0.248 0.560 
Caudal Middle Frontal 0.1 -0.028 0.035 0.435 0.765 
Caudal Middle Frontal 0.5 -0.040 0.035 0.257 0.695 
Caudal Middle Frontal 1 -0.031 0.036 0.381 0.843 
Entorhinal 0.01 -0.022 0.039 0.579 0.920 
Entorhinal 0.05 -0.024 0.039 0.531 0.894 
Entorhinal 0.1 -0.019 0.039 0.624 0.849 
Entorhinal 0.5 0.004 0.039 0.917 0.917 
Entorhinal 1 0.001 0.039 0.985 0.991 
Fusiform 0.01 -0.029 0.032 0.371 0.809 
Fusiform 0.05 -0.023 0.031 0.468 0.842 
Fusiform 0.1 -0.017 0.032 0.599 0.849 
Fusiform 0.5 -0.004 0.032 0.892 0.917 
Fusiform 1 -3.83×04 0.032 0.991 0.991 
Inferior Parietal 0.01 0.024 0.034 0.475 0.809 
Inferior Parietal 0.05 -0.012 0.033 0.707 0.895 
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Inferior Parietal 0.1 -0.011 0.033 0.744 0.853 
Inferior Parietal 0.5 -0.010 0.033 0.768 0.915 
Inferior Parietal 1 -0.011 0.034 0.737 0.843 
Inferior Temporal 0.01 -0.024 0.033 0.468 0.809 
Inferior Temporal 0.05 -0.055 0.032 0.086 0.348 
Inferior Temporal 0.1 -0.052 0.032 0.107 0.564 
Inferior Temporal 0.5 -0.049 0.032 0.128 0.575 
Inferior Temporal 1 -0.053 0.033 0.106 0.440 
Isthmus 0.01 -0.037 0.035 0.291 0.809 
Isthmus 0.05 -0.039 0.034 0.250 0.560 
Isthmus 0.1 -0.036 0.034 0.291 0.703 
Isthmus 0.5 -0.018 0.034 0.592 0.915 
Isthmus 1 -0.012 0.035 0.726 0.843 
Lateral Occipital 0.01 0.007 0.033 0.839 0.986 
Lateral Occipital 0.05 1.80×04 0.033 0.996 0.996 
Lateral Occipital 0.1 0.012 0.033 0.717 0.853 
Lateral Occipital 0.5 0.011 0.033 0.729 0.915 
Lateral Occipital 1 0.015 0.033 0.657 0.843 
Lateral Orbitofrontal 0.01 -0.006 0.032 0.847 0.986 
Lateral Orbitofrontal 0.05 -0.008 0.032 0.795 0.895 
Lateral Orbitofrontal 0.1 -0.007 0.032 0.822 0.853 
Lateral Orbitofrontal 0.5 -0.004 0.032 0.910 0.917 
Lateral Orbitofrontal 1 0.010 0.032 0.746 0.843 
Medial Orbitofrontal 0.01 -0.003 0.032 0.919 0.986 
Medial Orbitofrontal 0.05 -0.010 0.031 0.733 0.895 
Medial Orbitofrontal 0.1 -0.009 0.031 0.762 0.853 
Medial Orbitofrontal 0.5 -0.010 0.031 0.760 0.915 
Medial Orbitofrontal 1 -0.011 0.032 0.726 0.843 
Middle Temporal 0.01 -0.050 0.032 0.110 0.496 
Middle Temporal 0.05 -0.082 0.031 0.008 0.081 
Middle Temporal 0.1 -0.072 0.031 0.022 0.202 
Middle Temporal 0.5 -0.059 0.031 0.059 0.317 
Middle Temporal 1 -0.061 0.032 0.056 0.376 
Parahippocampal 0.01 -0.010 0.036 0.786 0.986 
Parahippocampal 0.05 -0.039 0.035 0.270 0.560 
Parahippocampal 0.1 -0.035 0.035 0.324 0.703 
Parahippocampal 0.5 -0.010 0.035 0.779 0.915 
Parahippocampal 1 -0.008 0.036 0.816 0.881 
Paracentral 0.01 -0.036 0.036 0.312 0.809 
Paracentral 0.05 -0.050 0.035 0.158 0.475 
Paracentral 0.1 -0.069 0.036 0.052 0.351 
Paracentral 0.5 -0.045 0.036 0.207 0.621 
Paracentral 1 -0.045 0.036 0.210 0.631 
Postcentral 0.01 0.027 0.032 0.388 0.809 
Postcentral 0.05 -0.003 0.031 0.916 0.951 
Postcentral 0.1 0.014 0.031 0.661 0.850 
Postcentral 0.5 -0.013 0.031 0.676 0.915 
Postcentral 1 -0.010 0.032 0.742 0.843 
Posterior Cingulate 0.01 -0.009 0.035 0.804 0.986 
Posterior Cingulate 0.05 -0.038 0.034 0.260 0.560 
Posterior Cingulate 0.1 -0.031 0.034 0.365 0.703 
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Posterior Cingulate 0.5 -0.065 0.034 0.059 0.317 
Posterior Cingulate 1 -0.055 0.035 0.114 0.440 
Precentral 0.01 -0.052 0.031 0.099 0.496 
Precentral 0.05 -0.080 0.030 0.009 0.081 
Precentral 0.1 -0.088 0.031 0.004 0.060 . 
Precentral 0.5 -0.082 0.031 0.008 0.222 
Precentral 1 -0.071 0.031 0.024 0.346 
Precuneus 0.01 -0.033 0.032 0.295 0.809 
Precuneus 0.05 0.006 0.031 0.857 0.926 
Precuneus 0.1 0.003 0.031 0.918 0.918 
Precuneus 0.5 0.021 0.031 0.507 0.855 
Precuneus 1 0.024 0.032 0.445 0.843 
Rostral Anterior Cingulate 0.01 -0.059 0.035 0.088 0.496 
Rostral Anterior Cingulate 0.05 -0.057 0.034 0.090 0.348 
Rostral Anterior Cingulate 0.1 -0.045 0.034 0.192 0.647 
Rostral Anterior Cingulate 0.5 -0.017 0.034 0.618 0.915 
Rostral Anterior Cingulate 1 -0.011 0.035 0.750 0.843 
Superior Parietal 0.01 -0.029 0.034 0.407 0.809 
Superior Parietal 0.05 -0.015 0.034 0.662 0.894 
Superior Parietal 0.1 -0.025 0.034 0.458 0.765 
Superior Parietal 0.5 -0.028 0.034 0.407 0.854 
Superior Parietal 1 -0.027 0.034 0.428 0.843 
Supramarginal 0.01 -0.047 0.033 0.154 0.596 
Supramarginal 0.05 -0.058 0.032 0.067 0.348 
Supramarginal 0.1 -0.049 0.032 0.127 0.564 
Supramarginal 0.5 -0.071 0.032 0.028 0.255 
Supramarginal 1 -0.072 0.033 0.028 0.346 
Frontal Pole 0.01 0.011 0.039 0.781 0.986 
Frontal Pole 0.05 -0.018 0.038 0.631 0.894 
Frontal Pole 0.1 -0.041 0.038 0.288 0.703 
Frontal Pole 0.5 -0.050 0.038 0.191 0.621 
Frontal Pole 1 -0.052 0.039 0.179 0.603 
Temporal Pole 0.01 -0.065 0.039 0.098 0.496 
Temporal Pole 0.05 -0.083 0.038 0.029 0.196 
Temporal Pole 0.1 -0.056 0.038 0.146 0.564 
Temporal Pole 0.5 -0.051 0.038 0.186 0.621 
Temporal Pole 1 -0.062 0.039 0.108 0.440 
Insula 0.01 -0.023 0.032 0.480 0.809 
Insula 0.05 -0.009 0.031 0.783 0.895 
Insula 0.1 0.008 0.032 0.793 0.853 
Insula 0.5 -0.023 0.032 0.461 0.854 
Insula 1 -0.024 0.032 0.453 0.843 
Superior Temporal Gyrus 0.01 -0.051 0.029 0.080 0.496 
Superior Temporal Gyrus 0.05 -0.041 0.028 0.150 0.475 
Superior Temporal Gyrus 0.1 -0.030 0.029 0.307 0.703 
Superior Temporal Gyrus 0.5 -0.023 0.029 0.433 0.854 
Superior Temporal Gyrus 1 -0.024 0.029 0.420 0.843 
Inferior Frontal Gyrus 0.01 -0.015 0.034 0.670 0.986 
Inferior Frontal Gyrus 0.05 -0.025 0.034 0.460 0.842 
Inferior Frontal Gyrus 0.1 -0.032 0.034 0.356 0.703 
Inferior Frontal Gyrus 0.5 -0.024 0.034 0.474 0.854 
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Inferior Frontal Gyrus 1 -0.018 0.034 0.606 0.843 
DorsoLateral Prefrontal Cortex 0.01 -0.081 0.024 0.001 0.023* 
DorsoLateral Prefrontal Cortex 0.05 -0.085 0.024 3.81×04 0.010* 
DorsoLateral Prefrontal Cortex 0.1 -0.081 0.024 0.001 0.024* 
DorsoLateral Prefrontal Cortex 0.5 -0.056 0.024 0.021 0.255 
DorsoLateral Prefrontal Cortex 1 -0.051 0.024 0.038 0.346 
Medial Occipital 0.01 -0.006 0.037 0.877 0.986 
Medial Occipital 0.05 0.016 0.036 0.649 0.894 
Medial Occipital 0.1 0.026 0.036 0.482 0.765 
Medial Occipital 0.5 0.027 0.036 0.456 0.854 
Medial Occipital 1 0.022 0.037 0.548 0.843 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
 
Table S8. Results for PGRS-SCZ*birth weight interactions on cortical thickness at all thresholds 
(n = 1,659) 
Cortical Thickness Effect Size SD p value p(FDR) 
Global 
Global 0.01 0.064 0.037 0.084 . 0.199 
Global 0.05 0.054 0.037 0.146 0.199 
Global 0.1 0.051 0.038 0.177 0.199 
Global 0.5 0.058 0.037 0.122 0.199 
Global 1 0.048 0.038 0.199 0.199 
Lobar 
Cingulate 0.01 0.068 0.035 0.049 0.145 
Cingulate 0.05 0.070 0.034 0.043 0.191 
Cingulate 0.1 0.055 0.035 0.118 0.311 
Cingulate 0.5 0.073 0.035 0.036 0.290 
Cingulate 1 0.063 0.035 0.072 0.513 
Frontal 0.01 0.043 0.038 0.253 0.387 
Frontal 0.05 0.028 0.037 0.450 0.600 
Frontal 0.1 0.024 0.038 0.524 0.699 
Frontal 0.5 0.027 0.038 0.469 0.536 
Frontal 1 0.022 0.038 0.574 0.656 
Insula 0.01 0.025 0.036 0.495 0.517 
Insula 0.05 0.013 0.036 0.723 0.826 
Insula 0.1 0.013 0.037 0.718 0.820 
Insula 0.5 0.039 0.037 0.290 0.464 
Insula 1 0.038 0.037 0.302 0.513 
Occipital 0.01 0.071 0.037 0.056 0.145 
Occipital 0.05 0.041 0.037 0.267 0.428 
Occipital 0.1 0.035 0.038 0.348 0.556 
Occipital 0.5 0.045 0.037 0.232 0.464 
Occipital 1 0.033 0.038 0.385 0.513 
Parietal 0.01 0.068 0.037 0.066 0.145 
Parietal 0.05 0.072 0.036 0.048 0.191 
Parietal 0.1 0.064 0.037 0.085 0.311 
Parietal 0.5 0.060 0.037 0.101 0.347 
Parietal 1 0.052 0.037 0.162 0.513 
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Postcentral 0.01 0.065 0.036 0.073 0.145 
Postcentral 0.05 0.046 0.036 0.199 0.398 
Postcentral 0.1 0.052 0.037 0.155 0.311 
Postcentral 0.5 0.034 0.036 0.349 0.465 
Postcentral 1 0.033 0.037 0.378 0.513 
Precentral 0.01 0.039 0.037 0.290 0.387 
Precentral 0.05 0.056 0.037 0.132 0.351 
Precentral 0.1 0.063 0.038 0.092 0.311 
Precentral 0.5 0.057 0.037 0.130 0.347 
Precentral 1 0.046 0.038 0.221 0.513 
Temporal 0.01 0.023 0.036 0.517 0.517 
Temporal 0.05 0.001 0.036 0.967 0.967 
Temporal 0.1 -0.001 0.036 0.979 0.979 
Temporal 0.5 0.010 0.036 0.782 0.782 
Temporal 1 0.002 0.037 0.959 0.959 
Parcellations 
Caudal Anterior Cingulate 0.01 0.044 0.041 0.287 0.516 
Caudal Anterior Cingulate 0.05 0.065 0.040 0.104 0.271 
Caudal Anterior Cingulate 0.1 0.057 0.041 0.164 0.342 
Caudal Anterior Cingulate 0.5 0.065 0.040 0.111 0.295 
Caudal Anterior Cingulate 1 0.062 0.041 0.130 0.352 
Caudal Middle Frontal 0.01 0.027 0.042 0.520 0.611 
Caudal Middle Frontal 0.05 0.046 0.042 0.267 0.527 
Caudal Middle Frontal 0.1 0.059 0.042 0.165 0.342 
Caudal Middle Frontal 0.5 0.058 0.042 0.170 0.354 
Caudal Middle Frontal 1 0.052 0.043 0.220 0.396 
Entorhinal 0.01 -0.055 0.043 0.205 0.450 
Entorhinal 0.05 -0.040 0.042 0.347 0.551 
Entorhinal 0.1 -0.042 0.043 0.336 0.566 
Entorhinal 0.5 -0.050 0.043 0.247 0.417 
Entorhinal 1 -0.058 0.044 0.183 0.352 
Fusiform 0.01 0.054 0.042 0.205 0.450 
Fusiform 0.05 0.015 0.042 0.712 0.819 
Fusiform 0.1 0.019 0.042 0.654 0.803 
Fusiform 0.5 0.024 0.042 0.573 0.673 
Fusiform 1 0.018 0.043 0.668 0.788 
Inferior Parietal 0.01 0.061 0.041 0.140 0.450 
Inferior Parietal 0.05 0.104 0.040 0.010 0.092 . 
Inferior Parietal 0.1 0.098 0.041 0.017 0.133 
Inferior Parietal 0.5 0.124 0.041 0.002 0.066 
Inferior Parietal 1 0.110 0.041 0.008 0.116 
Inferior Temporal 0.01 0.040 0.042 0.340 0.558 
Inferior Temporal 0.05 0.015 0.041 0.719 0.819 
Inferior Temporal 0.1 -0.003 0.042 0.940 0.974 
Inferior Temporal 0.5 -0.005 0.042 0.906 0.906 
Inferior Temporal 1 -0.011 0.042 0.801 0.832 
Isthmus 0.01 0.106 0.042 0.011 0.182 
Isthmus 0.05 0.119 0.041 0.004 0.092 . 
Isthmus 0.1 0.096 0.042 0.022 0.133 
Isthmus 0.5 0.116 0.042 0.005 0.073 
Isthmus 1 0.111 0.042 0.009 0.116 
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Cortical Thickness Effect Size SD p value p(FDR) 
Lateral Occipital 0.01 0.032 0.042 0.453 0.593 
Lateral Occipital 0.05 0.006 0.041 0.886 0.920 
Lateral Occipital 0.1 0.001 0.042 0.974 0.974 
Lateral Occipital 0.5 0.018 0.042 0.665 0.718 
Lateral Occipital 1 0.005 0.042 0.913 0.913 
Lateral Orbitofrontal 0.01 0.033 0.045 0.462 0.593 
Lateral Orbitofrontal 0.05 0.022 0.044 0.611 0.819 
Lateral Orbitofrontal 0.1 0.025 0.044 0.570 0.753 
Lateral Orbitofrontal 0.5 0.058 0.044 0.192 0.356 
Lateral Orbitofrontal 1 0.044 0.045 0.329 0.516 
Medial Orbitofrontal 0.01 0.031 0.044 0.483 0.593 
Medial Orbitofrontal 0.05 0.008 0.043 0.859 0.920 
Medial Orbitofrontal 0.1 -0.006 0.044 0.894 0.966 
Medial Orbitofrontal 0.5 0.021 0.044 0.627 0.706 
Medial Orbitofrontal 1 0.015 0.044 0.732 0.790 
Middle Temporal 0.01 0.011 0.042 0.796 0.860 
Middle Temporal 0.05 0.014 0.041 0.728 0.819 
Middle Temporal 0.1 -0.009 0.042 0.820 0.923 
Middle Temporal 0.5 -0.014 0.042 0.736 0.764 
Middle Temporal 1 -0.022 0.042 0.609 0.784 
Parahippocampal 0.01 -0.007 0.044 0.878 0.911 
Parahippocampal 0.05 -0.017 0.043 0.685 0.819 
Parahippocampal 0.1 -0.024 0.044 0.586 0.753 
Parahippocampal 0.5 -0.043 0.044 0.323 0.485 
Parahippocampal 1 -0.051 0.044 0.254 0.428 
Paracentral 0.01 0.055 0.045 0.217 0.450 
Paracentral 0.05 0.061 0.044 0.164 0.370 
Paracentral 0.1 0.087 0.044 0.051 0.191 
Paracentral 0.5 0.078 0.044 0.078 0.243 
Paracentral 1 0.068 0.045 0.131 0.352 
Postcentral 0.01 0.056 0.043 0.193 0.450 
Postcentral 0.05 0.046 0.042 0.273 0.527 
Postcentral 0.1 0.065 0.043 0.131 0.342 
Postcentral 0.5 0.044 0.043 0.307 0.485 
Postcentral 1 0.039 0.043 0.363 0.516 
Posterior Cingulate 0.01 0.019 0.042 0.652 0.733 
Posterior Cingulate 0.05 0.066 0.041 0.111 0.271 
Posterior Cingulate 0.1 0.065 0.042 0.119 0.342 
Posterior Cingulate 0.5 0.089 0.042 0.034 0.151 
Posterior Cingulate 1 0.080 0.042 0.058 0.302 
Precentral 0.01 0.058 0.044 0.181 0.450 
Precentral 0.05 0.093 0.043 0.030 0.115 
Precentral 0.1 0.113 0.043 0.010 0.133 
Precentral 0.5 0.093 0.043 0.032 0.151 
Precentral 1 0.080 0.044 0.067 0.302 
Precuneus 0.01 0.106 0.043 0.014 0.182 
Precuneus 0.05 0.109 0.042 0.010 0.092 
Precuneus 0.1 0.096 0.043 0.025 0.133 
Precuneus 0.5 0.095 0.042 0.026 0.151 
Precuneus 1 0.084 0.043 0.050 0.302 
Rostral Anterior Cingulate 0.01 0.062 0.042 0.139 0.450 
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Cortical Thickness Effect Size SD p value p(FDR) 
Rostral Anterior Cingulate 0.05 0.071 0.041 0.082 0.247 
Rostral Anterior Cingulate 0.1 0.053 0.041 0.201 0.388 
Rostral Anterior Cingulate 0.5 0.064 0.041 0.120 0.295 
Rostral Anterior Cingulate 1 0.060 0.042 0.152 0.352 
Superior Parietal 0.01 0.080 0.043 0.066 0.354 
Superior Parietal 0.05 0.104 0.043 0.015 0.102 
Superior Parietal 0.1 0.106 0.043 0.015 0.133 
Superior Parietal 0.5 0.105 0.043 0.015 0.134 
Superior Parietal 1 0.097 0.044 0.026 0.235 
Supramarginal 0.01 0.050 0.042 0.234 0.452 
Supramarginal 0.05 0.089 0.041 0.029 0.115 
Supramarginal 0.1 0.087 0.041 0.037 0.165 
Supramarginal 0.5 0.077 0.041 0.062 0.240 
Supramarginal 1 0.062 0.042 0.136 0.352 
Frontal Pole 0.01 -0.088 0.043 0.038 0.256 
Frontal Pole 0.05 -0.094 0.041 0.023 0.115 
Frontal Pole 0.1 -0.081 0.042 0.057 0.191 
Frontal Pole 0.5 -0.054 0.042 0.198 0.356 
Frontal Pole 1 -0.060 0.043 0.157 0.352 
Temporal Pole 0.01 -0.033 0.044 0.461 0.593 
Temporal Pole 0.05 -0.044 0.043 0.307 0.549 
Temporal Pole 0.1 -0.044 0.044 0.315 0.566 
Temporal Pole 0.5 -0.035 0.044 0.425 0.574 
Temporal Pole 1 -0.041 0.044 0.350 0.516 
Insula 0.01 -0.003 0.044 0.945 0.945 
Insula 0.05 0.001 0.043 0.979 0.979 
Insula 0.1 0.015 0.044 0.742 0.871 
Insula 0.5 0.064 0.044 0.145 0.326 
Insula 1 0.068 0.044 0.126 0.352 
Superior Temporal Gyrus 0.01 0.057 0.043 0.189 0.450 
Superior Temporal Gyrus 0.05 0.036 0.042 0.388 0.583 
Superior Temporal Gyrus 0.1 0.031 0.043 0.464 0.659 
Superior Temporal Gyrus 0.5 0.030 0.043 0.486 0.602 
Superior Temporal Gyrus 1 0.017 0.043 0.701 0.788 
Inferior Frontal Gyrus 0.01 0.034 0.043 0.428 0.593 
Inferior Frontal Gyrus 0.05 0.032 0.042 0.446 0.633 
Inferior Frontal Gyrus 0.1 0.037 0.043 0.391 0.587 
Inferior Frontal Gyrus 0.5 0.029 0.043 0.490 0.602 
Inferior Frontal Gyrus 1 0.018 0.043 0.679 0.788 
DorsoLateral Prefrontal Cortex 0.01 0.040 0.042 0.351 0.558 
DorsoLateral Prefrontal Cortex 0.05 0.041 0.042 0.325 0.549 
DorsoLateral Prefrontal Cortex 0.1 0.037 0.042 0.382 0.587 
DorsoLateral Prefrontal Cortex 0.5 0.035 0.042 0.402 0.571 
DorsoLateral Prefrontal Cortex 1 0.027 0.043 0.534 0.721 
Medial Occipital 0.01 0.092 0.044 0.038 0.256 
Medial Occipital 0.05 0.080 0.043 0.064 0.218 
Medial Occipital 0.1 0.065 0.044 0.141 0.342 
Medial Occipital 0.5 0.076 0.044 0.081 0.243 
Medial Occipital 1 0.060 0.044 0.178 0.352 
***p corr ≤ 0.001, **p corr ≤ 0.01, *p corr ≤ 0.05, . p corr ≤ 0.10 
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2.4 QQ-Plots of FDR Corrections  
QQ-Plots were created to demonstrate how FDR corrections were grouped. 
 
2.4.1 Global FDR Corrections: We corrected global cortical associations over the three cortical metrics 
(1 region (global) * 3 cortical measures * 1 PGRS-SCZ).  
 
 
Fig S3. QQ-plot showing observed and expected p values (-log10) for PGRS-SCZ and global 
cortical (thickness, volume and surface area) association before FDR correction.  
 
 
2.4.2 Regional FDR Corrections: Regional analyses were conducted post-hoc, on the condition that 
PGRS-SCZ global cortical associations were found. As a global CT effect was evident, we subsequently 
tested for regional association within each cortical metric individually. We first tested lobar and then 
parcellation structures and, due to a significant finding at this level. FDR corrections were thus 
calculated as follows: 1 cortical measure * 8 lobes * 1 PGRS-SCZ threshold; 1 cortical measure *27 
parcellations * 1 PGRS-SCZ threshold. 
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2.4.2.1 Lobar FDR Corrections  
     a)                                                                              b) 
   
                                                  c) 
             
 
 
 
 
 
 
 
Fig S4. QQ-plot showing observed and expected p values (-log10) for PGRS-SCZ associated with 
a) cortical thickness b) cortical volume and c) cortical surface area lobes before FDR correction. 
The groups identified in each plot are those which were used to conduct FDR corrections 
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2.4.2.2 Parcellation FDR Corrections  
   a)                                                                                             b) 
 
                                                   c) 
 
 
 
 
 
 
 
 
Fig S5. QQ-plot showing observed and expected p values (-log10) for PGRS-SCZ associated with 
a) cortical thickness b) cortical volume and c) cortical surface area parcellations before FDR 
correction. The groups identified in each plot are those which were used to conduct FDR corrections. 
These plots suggest that there is very little effect of PGRS-SCZ on surface area in comparison to cortical 
thickness and cortical volume. 
 
 
2.5 Post-hoc Power Analysis  
Power analyses were conducted using AVENGEME (https://sites.google.com/site/
fdudbridge/software/) (20, 21). Power was calculated for PGRS-SCZ associated with cortical structure 
and birth weight. Markers were assumed to be independent and 5% of SNPs were assumed to have an 
effect in the training sample as in a previous publication (22). Heritability of PGRS-SCZ and its genetic 
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covariance values with birth weight were calculated using LD score regression (v1.0.0(23)) analysis 
(PGRS-SCZ h2 = 0.017, rg = 0.023). However, rg could not be computed for PGRS-SCZ cortical 
structure; thus, hypothetical covariances of 0.01, 0.05, 0.1, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50 
were tested for this parameter. This range of values were tested in order to be inclusive however, the 
authors propose the more accurate covariances to be below 0.20 given that we would assume that the 
genetic covariance between PGRS-SCZ and cortical structure would be less than that between 
schizophrenia and bipolar disorder (rg = 0.20) (21) but higher than that of the calculated value for birth 
weight (rg = 0.004). Thus, the full range of covariances are reported in Table S9 with the write-up 
focusing on covariances below 0.20. 
 
2.5.1 PGRS-SCZ and Cortical Structure: We tested power at covariance values of 0.01, 0.05 and 0.1 
given a P threshold of ≤ 0.1. Power was calculated to be 5, 14 and 41%, respectively, with a sample 
size of 481,080, 41,218 or 21,508 individuals required to yield a power of 80% for each of these 
covariance values. See Table S9 for results at all other thresholds. 
 
2.5.2 PGRS-SCZ and Birth Weight: For associations with birth weight at the P ≤ 0.1 threshold, we 
calculated a power of 7%. To obtain power of 80% in this analysis, it was estimated that a sample size 
of 108,060 individuals would be required. 
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Table S9. Power calculations and required sample sizes for analysis of associations between 
PGRS-SCZ and cortical structure as well as PGRS-SCZ and birth weight 
 
Predictor 
Variable 
Response 
Variable 
PGRS P-value 
threshold 
Covar
iance 
Power p Sample Size 
Required 
PGRS-
SCZ 
Cortical 
Structure 0.01 
1% 0.055 0.308 481,080 
5% 0.169 0.156 41,218 
10% 0.511 0.026 21,508 
15% 0.848 0.002 15,721 
20% 0.979 3.97×-05 10,000 
25% 0.999 3.60×-07 10,000 
30% 1.000 1.19×-09 9,553 
35% 1.000 1.38×-12 8,452 
40% 1.000 5.48×-16 7,507 
45% 1.000 7.15×-20 6,697 
50% 1.000 2.94×-24 6,021 
  
0.05 
1% 0.054 0.309  
5% 0.152 0.174 
10% 0.453 0.036 
15% 0.791 0.003 
20% 0.959 1.29×-04 
25% 0.996 2.23×-06 
30% 1.000 1.62×-08 
35% 1.000 4.87×-11 
40% 1.000 5.90×-14 
45% 1.000 2.80×-17 
50% 1.000 5.03×-21 
0.1 
1% 0.053 0.310 
5% 0.140 0.185 
10% 0.413 0.045 
15% 0.743 0.005 
20% 0.936 2.88×-04 
25% 0.992 7.64×-05 
30% 1.000 9.48×-09 
35% 1.000 5.39×-10 
40% 1.000 1.38×-12 
45% 1.000 1.54×-15 
50% 1.000 7.42×-19 
0.5 
1% 0.053 0.312 
 5% 0.117 0.211 
10% 0.324 0.071 
15% 0.616 0.137 
20% 0.853 1.53×-03 
25% 0.964 9.86×-05 
30% 0.995 3.65×-06 
35% 1.000 8.95×-10 
40% 1.000 5.78×-12 
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45% 1.000 5.78×-12 
50% 1.000 2.03×-14 
1 
1% 0.052 0.312 
5% 0.114 0.214 
10% 0.314 0.075 
15% 0.600 0.015 
20% 0.840 1.82×-03 
25% 0.959 1.29×-04 
30% 0.993 5.38×-06 
35% 0.999 1.29×-07 
40% 1.000 1.77×-09 
45% 1.000 1.37×-11 
50% 1.000 5.93×-14 
PGRS-
SCZ 
Birth 
Weight 0.01 
 
 
0.4% 
0.076 0.269 
108,060 
  
0.05 0.072 0.275  
0.1 0.070 0.279 
0.5 0.064 0.288 
1 0.064 0.289 
 
 
Despite this study being the largest imaging PGRS study to date with 2,864 individuals (4, 24-26), it is 
still relatively small compared to other PGRS studies (e.g. (27, 28) n range = 10,036 – 35,754) and was 
underpowered (5-41%). This highlights the need for even larger imaging samples with current 
calculations suggesting a sample of ~21,500 individuals is required for adequate power. Given, UKB’s 
goal of completing 100,000 scans (https://imaging.ukbiobank.ac.uk/), this sample size should be 
achievable in the future. Samples of this size, coupled with larger discovery GWAS, will allow for 
detection of smaller effects (4, 29-31) and may eventually allow PGRS to be used in the development 
of personalised medicine (29), however further research would be necessary (32). 
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